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To determine whether aorta becomes immune organ in pathologies, we performed
transcriptomic analyses of six types of secretomic genes (SGs) in aorta and vascular
cells and made the following ﬁndings: 1) 53.7% out of 21,306 human protein genes are
classiﬁed into six secretomes, namely, canonical, caspase 1, caspase 4, exosome,
Weibel–Palade body, and autophagy; 2) Atherosclerosis (AS), chronic kidney disease
(CKD) and abdominal aortic aneurysm (AAA) modulate six secretomes in aortas; and
Middle East Respiratory Syndrome Coronavirus (MERS-CoV, COVID-19 homologous)
infected endothelial cells (ECs) and angiotensin-II (Ang-II) treated vascular smooth muscle
cells (VSMCs) modulate six secretomes; 3) AS aortas upregulate T and B cell immune
SGs; CKD aortas upregulate SGs for cardiac hypertrophy, and hepatic ﬁbrosis; and AAA
aorta upregulate SGs for neuromuscular signaling and protein catabolism; 4) Ang-II
induced AAA, canonical, caspase 4, and exosome SGs have two expression peaks of
high (day 7)-low (day 14)-high (day 28) patterns; 5) Elastase induced AAA aortas have
more inﬂammatory/immune pathways than that of Ang-II induced AAA aortas; 6) Most
disease-upregulated cytokines in aorta may be secreted via canonical and exosome
secretomes; 7) Canonical and caspase 1 SGs play roles at early MERS-CoV infected ECs
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whereas caspase 4 and exosome SGs play roles in late/chronic phases; and the early
upregulated canonical and caspase 1 SGs may function as drivers for trained immunity
(innate immune memory); 8) Venous ECs from arteriovenous ﬁstula (AVF) upregulate SGs
in ﬁve secretomes; and 9) Increased some of 101 trained immunity genes and decreased
trained tolerance regulator IRG1 participate in upregulations of SGs in atherosclerotic,
Ang-II induced AAA and CKD aortas, and MERS-CoV infected ECs, but less in SGs
upregulated in AVF ECs. IL-1 family cytokines, HIF1a, SET7 and mTOR, ROS regulators
NRF2 and NOX2 partially regulate trained immunity genes; and NRF2 plays roles in
downregulating SGs more than that of NOX2 in upregulating SGs. These results provide
novel insights on the roles of aorta as immune organ in upregulating secretomes and
driving immune and vascular cell differentiations in COVID-19, cardiovascular diseases,
inﬂammations, transplantations, autoimmune diseases and cancers.
Keywords: endothelial cell, canonical and noncanonical secretomes, inﬂammation, coronavirus infection, DAMPs

(27). However, signiﬁcant questions remain whether aorta serves
as an immune organ by upregulating secretomes during
atherosclerosis, AAA, and CKD; and whether aortic cells use
different secretomes to fulﬁll pathological functions in different
time courses.
Due to this vast coverage and the nature of being the ﬁrst cell
type to encounter any pathogen associated molecular patterns
(PAMPs)/DAMPs in the blood circulation, the endothelium
(endothelial cells, ECs) (28) could function as the primary
intravascular sentinel system (9, 29, 30), which is similar to
mucous membranes and skin to prevent microbial infections
originally deﬁned for immune system (https://clinicalinfo.hiv.
gov/en/glossary/immune-system). Thus, we compared ECs to
prototypic innate immune cells such as macrophages (31) in
more than 10 innate immune features, and proposed a new
paradigm that ECs are innate immune cells (2, 3, 32), which: 1)
serve as sentinels of the innate immune system; 2) acquire function
as antigen-presenting cells; 3) play immune enhancing and
immune suppressive roles depending on their cytokine secreting
panel; and 4) have plasticity to switch into other cell types (3, 32).
In support to our model, we recently characterized transcriptomic
changes of 1,311 innate immune regulatomic genes (33, 34) in ECs
infected with coronaviruses, and stimulated by DAMPs in 28 EC
microarray datasets with 7 monocyte datasets as controls. The
expressions of innate immune regulators (IGs) are modulated in
21 human EC transcriptomic datasets by various PAMPs/DAMPs,
namely, Middle East Respiratory Syndrome Coronavirus
[MERS-CoV, a virus homologous to Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV2, or COVID-19)],
lipopolysaccharide (LPS), lysophosphatidylcholine (LPC), shear
stress, hyperlipidemia and oxidized low-density lipoprotein
(oxLDL) (35). ECs execute innate antiviral machinery by
inducing expression of several immunomodulatory genes in
response to interferons (IFNs) and double-stranded RNA
(dsRNA) (36); and ECs have capacities in producing dsRNA
protein kinase and activating intrinsic and extrinsic apoptotic
pathways for restricting viral dissemination and eliminating viral
infection (37). In addition to PAMPs derived from microbes, ECs

INTRODUCTION
Atherosclerosis is a dominant and increasing cause of mortality
and morbidity worldwide. As a signiﬁcant molecular
mechanism, inﬂammation is a pathology from inception to the
emergency of complications (1–3), which has been validated in
atherogenesis by the ﬁndings from the Canakinumab Antiinﬂammatory Thrombosis Outcomes Study (CANTOS):
inhibition of interleukin-1b (IL-1b) reduces atherosclerotic
cardiovascular disease (4, 5). Aortic arch atherosclerosis as a
major atherosclerotic site (6) is an important source of
embolic stroke (7). We reported that hyperlipidemia drives
early atherosclerosis via disease risk sensing caspase 1inﬂammasome pathway (8–12). In addition, abdominal aortic
aneurysms (AAA), occurred in up to 8% of men aged >65 years,
remain asymptomatic until they rupture. Ruptured AAA and its
associated catastrophic pathological insult carry overall mortality
in excess of 80% and 2% of all deaths are AAA-related.
Pathologically, AAA is associated with inﬂammation, smooth
muscle cell apoptosis, and matrix degradation (13). During AAA
progression, inﬂammatory vascular smooth muscle cell (VSMC)
populations, inﬂammatory monocytes and macrophages are
signiﬁcantly increased in aortic lesions (14). Moreover, chronic
kidney disease (CKD) is associated with accelerated
cardiovascular disease (CVD) even when kidney function is
only mildly impaired; and the relative risk of all-cause death is
increased by approximately threefold in individuals with a serum
creatinine level greater than 150 mmol/l (15). Our reports showed
that CKD increases vascular inﬂammation via uremic toxins as
danger associated molecular patterns (DAMPs) (16–19)-caspase
1-inﬂamamsome (20) mediated pathway; and secretomes in
peripheral blood mononuclear cells (PBMC) may play
signiﬁcant roles in promoting inﬂammation in CKD transition
to end stage renal disease (21). Recently, we also reported that
CD4+Foxp3+ regulatory T cells (Treg) (22–25) may use various
secretomes to maintain Treg-ness (Treg suppression) (25),
modulate anti-tumor immune responses (26), facilitate tissue
repair (26) and stem cell-like functions in tissue regeneration
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express caspase 1/inﬂammasomes (38), one type of
PAMPs/DAMPs receptors (PRRs) (2), and sense metabolitesderived conditional DAMPs, as we reported (39, 40), from CVD
risk factors such as hyperlipidemia (8, 41), hyperhomocysteinemia
(42), uremia toxins associated with CKD (20), and hypoxia (12),
which activate ECs and accelerate vascular inﬂammation (17, 20)
and atherosclerosis (43, 44). Mitochondrial reactive oxygen species
(mtROS) and proton leak mediate a newly-termed physiological
and pathological activation (45–48). Moreover, under stimulation
by proatherogenic lipids chronic disease conditions such as
hyperlipidemia, ECs have a novel prolonged activation status, as
we reported, with four innate immune features, namely,
upregulation of EC adhesion molecules (49) and secretion of
cytokines and chemokines (50), upregulation of additional
DAMP receptors such as CD36, and increased expression of cosignaling receptors and MHC class II molecules (51).
Furthermore, the acetylation of histone 3 lysine 14 (H3K14) in
genomic regions that encode trained immunity enzymes in LPCactivated human aortic ECs (HAECs) is increased in comparison
to the genomic areas that encode for EC activation genes (52).
These ﬁndings suggest that the acetylation of H3K14 participates
in mediating innate immune memory (trained immunity, TI)
function of ECs, which are not suppressed by anti-inﬂammatory
and anti-EC activation cytokines IL-35 (53–55) and IL-10 (53, 56).
In addition to facilitating inﬂammatory cell trans-EC migration
and immune responses, EC increase the expression of T cell costimulation receptors and immune checkpoint receptors/T cell coinhibition receptors when stimulated by tumor necrosis factor-a
(TNFa) and IFNg (57), suggesting that EC may also play immune
tolerogenic function during inﬂammation via reverse signaling of
immune checkpoint receptors (31, 58). However, an important
question remained whether aortic cells and ECs have various
secretomes that are similar to that identiﬁed in monocytes and
macrophages (32, 59), making cytokine response ampliﬁed into
cytokine storms. In addition, secretomic gene expression changes
have not been extensively examined in aortic ECs and other
aortic cells.
Regardless of the signiﬁcant progress in understanding roles
of aortic cells in immune responses modulating the pathogenesis
of atherosclerosis, CKD-accelerated vascular inﬂammation and
AAA, a few important questions remained. First, whether aorta
serves as an immune organ by upregulating the expressions of
canonical and non-canonical secretomic genes (SGs) (21, 26) in
major metabolic CVD such as atherosclerosis, CKD-accelerated
vascular inﬂammation and AAA; second, whether under PAMPs
and DAMPs stimulation, vascular ECs and VSMCs are equipped
with different secretomic settings; third, whether various types of
SGs have differential roles in various diseases; and fourth,
secretomic genes upregulated in diseases and PAMPs and
DAMPs stimulation are partially regulated by reactive oxygen
species (ROS) regulators and trained immunity regulators (60).
Our new transcriptomic results in addressing these issues
provide novel insights on the roles of aortic cell and vascular
cell secretomes in COVID-19 related virus infection, CVDs,
inﬂammations, transplantation, autoimmune diseases,
and cancers.
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MATERIALS AND METHODS
Aorta Transcriptomics Data and
Database Content
Aorta and endothelial cell transcriptomics datasets were collected
from the National Institutes of Health (NIH)–National Center for
Biotechnology Information (NCBI)–Gene Expression Omnibus
(GEO) (https://www.ncbi.nlm.nih.gov/gds/) and ArrayExpress
(https://www.ebi.ac.uk/arrayexpress/) databases and analyzed with
online software GEO2R (https://www.ncbi.nlm.nih.gov/geo/geo2r/),
namely, atherosclerotic mouse aorta (GSE10000) and CKD affected
rat aorta (GSE146638), abdominal aortic aneurysm in aortas of
patients (GSE47472), aorta of Ang-II induced aneurysm model
(GSE17901), aorta of elastase induced aneurysm (GSE51229),
venous endothelial cell from arteriovenous ﬁstula (GSE46126),
MERS-CoV infection in human endothelial cells (GSE79218) and
Ang-II treated vascular smooth muscle cells (GSE97470). Thus, a
total of 8 datasets were analyzed. In addition, we organized six
secretomic pathway gene lists from previous publications, namely,
canonical secretome (Atlas website (https://www.proteinatlas.org/)),
caspase 1-Gasdermin D (caspase 1) secretome (PMID 18329368),
caspase 4-Gasdermin D (caspase 4) secretome (PMID28196878),
exosome secretome (http://exocarta.org/download), Weibel-Palade
bodies (WPB) (PMID 22468712) and autophagy secretome (PMID:
29941450, PMID:30894055, PMID:33363205, PMID: 25988755,
PMID: 32332096, PIMD: 31972172) (Figure 1A).

Metascape Analysis
Metascape (https://metascape.org/gp/index.html#/main/step1)
was used for enrichment analysis. This website contains the
core of most existing gene annotation portals (Table 1).

Ingenuity Pathway Analysis (IPA)
We utilized Ingenuity Pathway Analysis (IPA, Qiagen, https://www.
qiagenbioinformatics.com/products/ingenuity-pathwayanalysis/) to
characterize clinical relevance and molecular and cellular functions
related to the identiﬁed genes in our microarray analysis.
Differentially expressed genes were identiﬁed and uploaded into
IPA for analysis. The core and pathways analysis were used to
identify molecular and cellular pathways.

RESULTS
Approximately 53.7% out of 21,306 human
protein-encoding genes are classiﬁed into
six secretomes; canonical, caspase 1,
caspase 4 and exosomes, are the large
secretomes with >900 proteins; and six
secretomes are ranked from high to low in
speciﬁcity as exosome (83%), >canonical
(68%), >caspase 1 (56%), >caspase 4
(49%), >autophagy (37.5%), and >WPB
(8%).
It remains unknown whether aortic vascular cells such as ECs use
canonical secretome (secretory proteins with signal peptide)
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B

FIGURE 1 | The 53.7% out of 21,306 human protein genes can be classiﬁed into six secretomes. (A) Six secretomes, canonical (with signal peptide), caspase-1
(secretome mediated via N-terminal gasdermin D protein-formed channel when caspase-1 is activated), caspase-4 (secretome mediated via N-terminal gasdermin D
protein-formed protein channel when caspase-4 (humans)/caspase-11 (mice) is activated) and exosomes, are the large secretomes with > 900 proteins, WeibelPalade bodies (WPB), and autophagy secretome. (B) Venn Diagram Analysis was used to classify all the secretory protein genes into the secretome-shared genes
and secretome-speciﬁc genes in six secretomes, which are ranked from the highest speciﬁcity to the lowest as exosome (83%) > canonical (68%) > caspase-1
(56%) > caspase-4 (49%) > autophagy (37.5%) > WPB (8%).

Our results have demonstrated that some secretory proteins can be
secreted via different secretomes. Based on their speciﬁcities, we
ranked six secretomes from high to low in speciﬁcities as
exosome secretome (83%) > canonical secretome (68%) >
caspase 1 secretome (56%) > caspase 4 secretome (49%) >
autophagy secretome (37.5%) > WPB secretome (8%).
We then hypothesized that each secretomic protein carries out
speciﬁc cellular functions. To examine this hypothesis, we
analyzed the SGs with the Metascape signaling database (https://
metascape.org/gp/index.html#/main/step1). As the top function
pathways listed in Tables 1A–C, canonical secretome carried out
ten speciﬁc pathways, namely, actin ﬁlament based process,
regulated exocytosis (shared with caspase 4 secretome, exosome
secretome), hemostasis, signaling by receptor tyrosine kinase,
organelle localization, cell morphogenesis involved in
differentiation, regulation of cell adhesion (shared with WPB
secretome), adaptive immune system (shared with caspase 4
secretome), membrane trafﬁcking, and cellular response to
nitrogen compound. Caspase 1 secretome carried out ten
speciﬁc pathways, namely, negative regulation of supramolecular
ﬁber organization, transcription of HIV genome, oxidative
phosphorylation, CDC5L complex (positive regulator of cell
cycle G2/M progression), mRNA catabolic process, chaperone
mediated protein transport, positive regulation of viral process,
NABA extracellular matrix (ECM) glycoproteins, cell–cell
communications, and interconversion of nucleotide di- and
triphosphates. Caspase 4 secretome carried out nine speciﬁc
pathways, namely, small molecule catabolic process, aromatic
compound catabolic process, cofactor metabolic process,
oxidation reduction process, alpha amino acid metabolic
process, cysteine and methionine metabolism, platelet

(21), caspase 1-Gasdermin D (caspase 1) secretome, caspase 4Gasdermin D (caspase 4) secretome, exosome secretomes (23),
Weibel–Palade bodies (WPB), and autophagy secretome. We
hypothesized that the expressions of aortic vascular cell
canonical secretome, ﬁve types of noncanonical secretomes
such as caspase 1, caspase 4, exosomes, WPB, and autophagy
secretome are differentially modulated in aortic vascular cells in
metabolic CVDs and coronavirus infection. To examine this
hypothesis, as shown in Figures 1A, B, we collected six types of
secretomes with a total of 11,440 proteins, namely, canonical
secretome (signal peptide-mediated exocytic secretory pathway;
2,640 proteins (21), caspase 1-dependent noncanonical
secretome (non-signal peptide-mediated; 964 proteins) (61),
caspase 4-dependent noncanonical secretome (1,223 proteins)
(62), exosome secretome (6,560 proteins, downloaded from a
comprehensive exosome database http://exocarta.org/download)
(23), WPB secretome (37 proteins) and autophagy secretome (16
proteins). Of note, most updated human protein-coding genes
are 21,306 (63), suggesting that 53.7% of human proteins (11,440
secretory protein genes in the six secretomes out of 21,306
human protein-encoding genes) carry out secretory functions
physiologically and/or patho-physiologically.
We performed Venn diagram analysis to determine the
overlaps between six types of secretomes. As shown in
Figure 1B, canonical secretome had 1,794 speciﬁc secretomic
genes (SGs) out of 2,640 SGs (68%); caspase 1 dependent
secretome had 536 speciﬁc SGs out of 964 SGs (56%); caspase 4
dependent secretome had 598 speciﬁc SGs out of 1,223 SGs (49%);
exosome secretome had 5,443 speciﬁc SGs out of 6,560 (83%);
WPB secretome had 3 speciﬁc SGs out of 37 SGs (8%); and
autophagy secretome had 6 speciﬁc SGs out of 16 SGs (37.5%).
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TABLE 1 | The most 89 top functional pathways carried out by ﬁve secretomes are secretome-speciﬁc and are not shared by other secretomes, suggesting that ﬁve secretomic mechanisms have different functions.

Canonical Canonical Canonical Canonical Canonical Caspase1 Caspase1 Caspase1 Caspase4 Caspase4 Exosomes Exosome
Speciﬁc Caspase1 Caspase4 Exosomes
WPB
Speciﬁc Caspase4 Exosomes Speciﬁc Exosomes Speciﬁc
WPB

5

Actin ﬁlament based process
Regulated exocytosis
Hemostasis
Signaling by Receptor Tyrosine Kinases
Organelle localization
Cell morphogenesis involved in differentiation
Regulation of cell adhesion
Adaptive immune system
Membrane Trafﬁcking
Cellular response to nitrogen compound
DNA conformation change
Cell substrate adherens junction assembly
Regulation of mRNA metabolic process
Detoxiﬁcation of ROS
Orc1 removal from chromatin
Disease of signal transduction by growth factor receptors
and second messengers
Stem cell differentiation
establishment of protein localization to endoplasmic
reticulum
Cellular response to abiotic stimulus
actomyosin structure organization
Leukocyte degranulation
Endocytosis
RHO GTPase Effectors
Golgi vesicle transport
positive regulation of organelle organization
phagocytosis
Establishment of organelle localization
regulation of leukocyte activation
cytosolic transport

1
1
1
1
1
1
1
1
1
1

1

1

1

1
1

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

1

The signal pathways of the gene list from Figure 1B with 12 groups were analyzed by Metascape (https://metascape.org/gp/index.html#/main/step1).

Canonical
Speciﬁc
NABA matrisome associated
extracellular structure organization
NABA core matrisome
humoral immune response
complement and coagulation cascades
NABA secreted factors

Canonical
Caspase1

Canonical
Caspase4

Canonical
Exosomes
1
1
1
1
1
1

Canonical
WPB

Caspase1
Speciﬁc

Caspase1
Caspase4

Caspase1
Exosomes

Caspase4
Speciﬁc

Caspase4
Exosomes

Exosomes
Speciﬁc

Exosome
WPB

1
1
1

(Continued)
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TABLE 1 | Continued
Table 1B
Canonical
Speciﬁc

Canonical
Caspase1

Canonical
Caspase4

Canonical
Exosomes

6

negative regulation of proteolysis
regulation of IGF transport and uptake by IGFBPs
response to wounding
Cell surface interactions at the vascular wall
Peptidyl tyrosine phosphorylation
negative regulation of supramolecular ﬁber organization
transcription of the HIV genome
oxidative phosphorylation
CDC5L complex
mRNA catabolic process
chaperone mediated protein transport
positive regulation of viral process
NABA ECM Glycoproteins
Cell-cell communication
Interconversion of nucleotide di-and triphosphates
organic cyclic compound catabolic process
carbon metabolism
protein folding
IL12 mediated signaling pathway
HIF-1 signaling pathway
pentose phosphate metabolism
establishment of protein localization to organelle
cellular response to oxidative stress

Canonical
WPB

Caspase1
Speciﬁc

Caspase1
Caspase4

Caspase1
Exosomes

Caspase4
Speciﬁc

Caspase4
Exosomes

Exosomes
Speciﬁc

Exosome
WPB

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Table 1C
Canonical
Speciﬁc

Canonical
Caspase4

Canonical
Exosomes

Canonical
WPB

Caspase1
Speciﬁc

Caspase1
Caspase4

Caspase1
Exosomes

Caspase4
Speciﬁc

Caspase4
Exosomes

1
1
1
1
1

Exosomes
Speciﬁc

Exosome
WPB

1
1
1
1
1
1
1
1
1
1
1
1
(Continued)
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Defective EXT2 causes exostoses 2
cell substrate adhesion
VEGFA VEGFR2 signaling pathway
positive regulation of cytokine production
chemotaxis
small molecule catabolic process
aromatic compound catabolic process
cofactor metabolic process
oxidation reduction process
alpha amino acid metabolic process
cysteine and methionine metabolism
platelet degranulation
drug catabolic process
purine ribonucleoside metabolic process
myeloid leukocyte activation
positice regulation by host of viral process

Canonical
Caspase1

Aorta is an Immune Organ

1
1
1
1
1
1
1

1
1
1
1
1
1
1

Exosomes
Speciﬁc
Canonical
WPB

Caspase1
Speciﬁc

Caspase1
Caspase4

Caspase1
Exosomes

Caspase4
Speciﬁc

Caspase4
Exosomes

degranulation, drug catabolic process, and purine ribonucleoside
metabolic process. Exosome secretome carried out eight speciﬁc
pathways, namely, response to virus, cytokine–cytokine receptor
interaction, defense system to other organism, G protein-coupled
receptor (GPCR) ligand binding, phosphoinositide 3-kinase
(PI3K)-protein B kinase (PKB, Akt) signaling pathway,
glycoprotein metabolic process, skeletal system development,
and aminoglycan metabolic process. Of note, autophagy had 6
speciﬁc SGs, for which no speciﬁc pathways were found in this
analysis. In addition, canonical and caspase 1 secretomes shared
10 speciﬁc pathways, canonical and caspase 4 shared ten speciﬁc
pathways, canonical and exosome secretomes shared ten
speciﬁc pathways, canonical and WPB secretomes shared 3
speciﬁc pathways, caspase 1 and caspase 4 secretomes shared
ten speciﬁc pathways, caspase 1 and exosome secretomes
shared 5 speciﬁc pathways, caspase 4 and exosome secretomes
shared 10 speciﬁc pathways, and exosome and WPB
secretomes shared one speciﬁc pathway.
Taken together, our results have demonstrated that ﬁrst,
53.7% out of 21,306 human protein-encoding genes in the six
secretomes carry out secretory functions physiologically and
pathophysiologically; second, out of six types of secretomes,
canonical, caspase 1, caspase 4 and exosome secretomes are the
large secretomes with more than 900 proteins; and third,
although different types of secretomes share some functions
such as regulated exocytosis, regulation of cell adhesion, innate
and adaptive immune systems, positive regulation of organelle
organization (64), and others, except autophagy secretome, ﬁve
types of secretomes have speciﬁc functional pathways.

1

Exosome
WPB

Lu et al.

Canonical
Caspase4

Canonical
Exosomes

Atherosclerosis, CKD, and AAA
Signiﬁcantly Modulate the Expression of
Six Secretomes in Aortas; and MERS-CoV
Infection in Human Endothelial Cells and
Angiotensin-II Treatment in Vascular
Smooth Muscle Cells Also Modulate the
Expression of Six Secretomes.

regulation of endothelial cell proliferation
carbohydrate derivative catabolic process
intermembrane lipid transfer
fatty acid derivative biodynthetic process
metabolism of vitamins and cofactors
rhythmic process
response to virus
Cytokine-cytokine receptor interaction
defense response to other organism
GPCR ligand binding
PI3K-akt signaling pathway
glycoprotein metabolic process
skeletal system development
aminoglycan metabolic process
response to unfolded protein

Table 1C

TABLE 1 | Continued

Canonical
Speciﬁc

Canonical
Caspase1

We proposed a new working model that ECs are innate immune
cells (3, 32, 65); and more than 20 cytokines have been reported
to play roles in mediating EC responses to inﬂammation in CVD
(2, 12, 33, 50, 53, 54, 56, 66–69), immune responses (69), EC-tomesenchymal transition (70, 71). However, a panoramic view on
transcriptomic changes of whole SGs in ECs remained unknown.
We hypothesized that SGs in aortic vascular cells have
transcriptomic changes in response to PAMPs from viruses,
and DAMPs derived from the risk factors of cardiovascular
and metabolic diseases such as hyperlipidemia (9, 10, 39, 40,
44, 72), CKD (16, 18–21), and AAA (31).
We and others reported that the Nod-like receptor family 3
(NLRP3) promotes human aortic EC activation (41) induced by
oxLDL and LPC (8, 10, 73). The inﬂammatory cell death
(pyroptosis) (9) carried out by caspase 1 (38) canonical,
caspase 4 (humans)/caspase 11 (mice) noncanonical
inﬂammasomes (74)-gasdermin D (75) pathway has been
reported to mediate EC pyroptosis (inﬂammatory cell death)
(76). Due to their content enriched in proteins, mRNAs and
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FIGURE 2 | The three major aortic diseases including atherosclerosis, chronic kidney disease (CKD), and abdominal aortic aneurysm (AAA) signiﬁcantly modulate
the expression of six secretomes in aortas (A–C), suggesting that aorta is a new immune and endocrine organ in pathologies. Middle East Respiratory Syndrome
Coronavirus (MERS-CoV) infection in human endothelial cells and Angiotensin-II (Ang-II) treatment in vascular smooth muscle cells also modulate the expression of
six secretomes (A–C), suggesting that in response to danger associated molecular pattern (DAMPs, Ang-II) pathogens-associated molecular pattern (PAMPs,
MERS-CoV) major aortic cell types such as endothelial cells and vascular smooth muscle cells modulate the expression of six secretomes. (D) Atherosclerosis and
chronic kidney disease modulate the expression of secretomic genes much more than abdominal aortic aneurysm. (E) Angiotensin-II upregulates the expression of
secretomic genes much more than downregulating the expression of secretomic genes where MERS-CoV infection downregulates more than upregulates the
expression of secretomic genes. P < 0.05 |LogFC|>1. LogFC>1 or < -1.

secretome, and upregulated 25% and downregulated 6.2%
autophagy secretome. In addition, MERS coronavirus infection
in human ECs upregulated 8.8% and downregulated 10.8% of
canonical secretome, upregulated 2.7% and downregulated 2.8%
of caspase 1 secretome, upregulated 4.5% and downregulated
6.6% caspase 4 secretome, upregulated 10.1% and downregulated
11.9% of exosome secretome, upregulated 5.4% and
downregulated 18.9% of WPB secretome, and upregulated
6.3% and downregulated 18.8% autophagy secretome.
Moreover, CKD upregulated 4.9% and downregulated 2.0% of
canonical secretome, upregulated 1.3% and downregulated 0.7%
of caspase 1 secretome, upregulated 2.5% and downregulated
0.8% of caspase 4 secretome, upregulated 3.2% and
downregulated 1.5% of exosome secretome, upregulated 8.1%
and downregulated 2.7% of WPB secretome, and upregulated
12.5% and downregulated 0% autophagy secretome.
Furthermore, AAA upregulated 0.9% and downregulated 3.3%
of canonical secretome, upregulated 0.4% and downregulated
1.4% of caspase 1 secretome, upregulated 0.6% and
downregulated 1.5% caspase 4 secretome, upregulated 1.0%
and downregulated 2.8% of exosome secretome, upregulated
0% and downregulated 2.7% of Weibel–Palade body secretome,
and upregulated 0% and downregulated 0% autophagy secretome.
We then hypothesized that upregulation and downregulation
of secretomes are different in various diseases. As shown in

noncoding RNAs, exosome secretomes carry out cell–cell
communication and promote tissue regeneration, wound
healing, extracellular matrix remodeling, immunomodulation
(23), angiogenesis, anti-apoptotic activity and cell migration,
proliferation and differentiation (77). In addition, autophagy
has unconventional protein secretion (78), which share with
extracellular vesicles the molecular mechanisms, namely, with
notable crosstalk such as amphisomes and “secretory autophagy”
(79). Moreover, ECs have speciﬁc WPB secretome (80).
We hypothesized that metabolic CVD such as atherosclerotic
mouse aorta and CKD affected rat aorta, MERS-CoV infection in
human ECs and AAA in aortas of patients differentially regulate
the expression of various types of secretomes. To examine this
hypothesis, as shown in Figure 2A, we collected microarray and
RNA-sequencing data from atherosclerotic apolipoprotein E
deﬁcient (ApoE − / − ) aorta, CKD accelerated vascular
inﬂammation in rat aorta, MERS-CoV infected human ECs
and AAA in patients aortas, deposited in the NIH/NCBIGeoDatasets database (https://www.ncbi.nlm.nih.gov/gds). As
shown in Figures 2B, C, atherosclerosis upregulated 9.8% and
downregulated 5.5% of canonical secretome, upregulated 2.6%
and downregulated 0.9% of caspase 1 secretome, upregulated
6.1% and downregulated 1.3% caspase 4 secretome, upregulated
7.8% and downregulated 3.7% of exosome secretome,
upregulated 16.2% and downregulated 2.7% of WPB
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Figure 2D, the ratios of upregulation versus downregulation of
canonical secretome, caspase 1 secretome, caspase 4 secretome,
exosome secretome, WPB secretome and autophagy secretome
in atherosclerosis, CKD, and AAA were high in atherosclerosis
and CKD. In contrast, the ratios of upregulation versus
downregulation of secretomic genes were low in AAA
(Figure 2C), which were lower than 0.5 in AAA. In addition,
WPB secretomes and autophagy secretome were modulated in
atherosclerosis, and CKD much high than that in AAA. The
modulation patterns of canonical and exosome secretomes in
atherosclerosis, CKD and AAA were similar; and the modulation
scales of caspase 4 secretome were bigger than that of caspase 1
secretome in these four diseases.
We then hypothesized that the percentages of modulation
(upregulation and downregulation) of each type of secretomic
genes are different in various vascular cells. As shown in
Figures 2C, E, MERS-CoV infection modulated all types of
secretomes in human microvascular ECs with upregulation of
231 (8.75%) canonical secretomic genes, 26 (2.71%) caspase 1
secretomic genes, 55 (4.5%) caspase 4 secretomic genes, 664
(10.12%) exosome secretomic genes, 2 (5.41%) WPB secretomic
genes and one (6.25%) autophagy secretomic gene, respectively.
In addition, MERS infection also downregulated 286 (10.83%)
canonical secretomic genes, 27 (2.81%) caspase 1 secretomic
genes, 81 (6.62%) caspase 4 secretomic genes, 778 (11.86%)
exosome secretomic genes, 7 (18.92%) WPB secretomic genes
and 3 autophagy secretomic genes, respectively. Of note, MERS
infection downregulated more than upregulated the secretomic
genes in MERS-CoV-infected ECs (Figure 2D). In comparison,
angiotensin-II (Ang-II) treatment of rat VSMCs modulated the
expression of all six major secretomes with upregulation of 167
(6.33%) canonical secretomic genes, 38 (3.94%) caspase 1
secretomic genes, 67 (5.48%) caspase 4 secretomic genes, 547
(8.34%) exosome secretomic genes, 4 WPB secretomic genes and
one autophagy secretomic gene, respectively. In addition, Ang-II
treatment of VSMC downregulated 167 (6.33%) canonical
secretomic genes, 15 (1.56%) caspase 1 secretomic genes, 33
(2.7%) caspase 4 secretomic genes, 404 (6.16%) exosome
secretomic genes, 3 (8.11%) WPB secretomic genes and 0
autophagy secretomic gene, respectively. The ratios of
upregulation versus downregulation of caspase 1 secretomic
genes (250%) and that of caspase 4 secretomic genes (200%)
were much bigger than that of other secretomic genes
(Figure 2D), suggesting that signiﬁcant roles of caspase 1
secretome and caspase 4 secretome in Ang-II treated VSMC
inﬂammatory responses (81). The ratios of upregulation versus
downregulation of secretomic genes in Ang-II treated VSMC
were much higher than that of MERS-CoV infected human ECs
(Figure 2D). Of note, due to the differences in experimental
conditions and cell types in Ang-II treated VSMC and Ang-II
induced AAA, the ratios of upregulation versus downregulation
of secretomic genes in Ang-II treated VSMC (>1) and AAA (<1)
were different.
Taken together, our data have demonstrated that ﬁrst,
atherosclerosis and CKD signiﬁcantly modulate the expression
of six types of secretomes, but AAA modulate the expression of six
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types of secretomes much less; second, the ratios of upregulation
versus downregulation of secretomic genes in atherosclerosis and
CKD were much higher than that in AAA. In contrast, the ratios
of upregulation versus downregulation of secretomic genes were
low in AAA, suggesting that atherosclerosis and CKD-aorta need
more general secretomic functions than AAA, but AAA require
more focused secretomic functions than atherosclerosis and CKDaorta; third, in addition to global secretomic genes analysis in
aorta, we also examined the expressions of vascular cell secretomic
genes. Ang-II treatment of aortic VSMCs and MERS-CoVinfection of ECs signiﬁcantly modulate the expression of SGs.
The ratios of upregulation versus downregulation of caspase 1 SGs
and that of caspase 4 SGs are much bigger than that of other SGs
in Ang-II treated VSMCs; and the ratios of upregulation versus
downregulation of SGs in Ang-II treated VSMC are bigger than
that of MERS-infected ECs, and fourth, canonical secretome,
exosome secretome, WPB secretome, and autophagy secretome
are general pathology secretomes except WPB secretome in
atherosclerosis but caspase 1 secretome and caspase 4 secretome
are DAMP receptors-focused and inﬂammatory secretomes such
as chronic inﬂammation, namely, atherosclerosis, CKD, and AngII treated VSMC.

Atherosclerotic Aortas Upregulate T Cell
and B Cell Adaptive Immune Secretomic
Genes; CKD Aortas Upregulate
Secretomic Genes for Cardiac
Hypertrophy, Hepatic Fibrosis and
Senescence; and AAA Aortas Upregulate
Secretomic Genes for Neuromuscular
Signaling, Protein Catabolic Process and
Fcg Receptor-Mediated Phagocytosis
We hypothesized that each type of secretomic genes play
different roles in diseases. To examine this hypothesis, we
analyzed the functional signaling pathways in differentially
modulated secretomic genes in each disease setting. As shown
in Figure 3A, for example, canonical secretomic genes in
atherosclerotic aortas had metabolic and inﬂammatory
functions, namely, D-myo-inositol (1,4,5,6)-tetrakisphosphate
biosynthesis, D-myo-inositol (3,4,5,6)-tetrakisphosphate
biosynthesis, 3-phosphoinsitide degradation, D-myo-inositol 5phosphate metabolism, 3-phosphoinsitide biosynthesis,
lipopolysaccharide (LPS)/IL-1 mediated inhibition of retinoid
X receptor (RXR) function, dendritic cell maturation, Toll-like
receptor signaling, IL-6 signaling, and acute phase response
s i g n a l i n g . C a s p a s e 1 - G S D M D s e c r e t o m i c g e n e s in
atherosclerosis had various pathophysiological functions,
namely, actin cytoskeleton signaling, leukocyte extravasation
signaling, estrogen receptor signaling, actin nucleation by
Actin Related Protein 2/3 complex (ARP)-Wiskott–Aldrich
syndrome protein (WASP) complex, integrin signaling,
synaptogenesis signaling, Rac signaling, Ephrin receptor
signaling, and colorectal cancer metastasis signaling. Caspase
4-GSDMD secretomic genes in atherosclerosis had various
pathophysiological functions with B cell signaling, namely, role
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FIGURE 3 | Atherosclerosis (AS) aortas upregulate T and B cell immune secretomic genes (SGs); chronic kidney disease (CKD) aortas upregulate SGs for cardiac
hypertrophy and hepatic ﬁbrosis; and abdominal aortic aneurysm (AAA) aortas upregulate SGs for neuromuscular signaling and protein catabolism. (A) Ingenuity
Pathway Analysis (IPA) analysis of upregulated genes in Fig. 2B. Atherosclerotic aortas upregulate expression of T cell and B cell adaptive immune secretomic genes;
(B) chronic kidney disease (CKD) aortas upregulate expression of secretomic genes for cardiac hypertrophy, hepatic ﬁbrosis, and senescence; and (C) Aortic
aneurysm aortas upregulate expression of secretomic genes for neuromuscular signaling, protein catabolic process, and immunoglobulin Fc gamma (g) receptormediated phagocytosis. Z score>1.

hemostasis, blood coagulation, platelet activation, negative
regulation of cell adhesion, response to endoplasmic reticulum
stress, and supramolecular ﬁber organization. Autophagy SGs in
atherosclerosis had functions such as pathway interaction
database (PID) (83) IL27 pathway (https://maayanlab.cloud/
Harmonizome/dataset/PID+Pathways), positive regulation of
response to external stimulus, PID AP1 pathway, and
regulation of protein kinase activity. These results have
demonstrated that atherosclerotic aorta cells modulate different
SGs for different functions with cell-type speciﬁcities. For
example, canonical secretomic genes for metabolic
reprogramming, inﬂammation; caspase 1-secretomic genes for
cytoskeletal signaling, leukocyte extravasation signaling; caspase
4 SGs for B cell signaling and NFAT-related cytokine signaling;
exosome SGs for T cell signaling and autoimmune signaling;
Weibel–Palade body SGs for blood coagulation and platelet

of nuclear factor of activated T cells (NFAT) in regulation of
immune response, B cell receptor signaling, IL-8 signaling,
neuroinﬂammation signaling, role of protein kinase R (PKR) in
interferon induction and antiviral response, Rac signaling, fMLP
signaling in neutrophils, Ephrin receptor signaling, endothelin 1
signaling, and systemic lupus erythematosus in B cell signaling.
Exosome secretomic genes in atherosclerosis had various
pathophysiological functions with T cell signaling, namely,
oncostatin M signaling, platelet derived growth factor (PDGF)
signaling, type-I diabetes signaling (autoimmune), role of NFAT
in regulation of immune response (82), cell cycle control of
chromosomal replication, type 1 T helper cell (Th1) pathway,
systemic lupus erythematosus in B cell signaling, CD28 signaling
in T helper cells, neuroinﬂammation signaling, and PKCq
signaling in T cells. Weibel–Palade body SGs in atherosclerosis
had coagulation and platelet activation functions, namely,
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phagocytosis in macrophages and monocytes, Rho (a small
GTPase protein) GDP-Dissociation Inhibitors (RhoGDI)
signaling and mTOR signaling. Exosome SGs in AAA aortas
had functional pathways, namely, RhoGDI signaling, Signal
transducer and activator of transcription 3 (STAT3) pathway,
renal carcinoma signaling, senescence pathway, G proteincoupled receptor (GPCR)-mediated integration of
enteroendocrine signaling, role of MAPK signaling inhibiting
the pathogenesis of inﬂuenza, endocannabinoid cancer
inhibition pathway, IL-6 signaling, programmed death-1 (PD1), programmed death ligand 1 (PD-L1) cancer immunotherapy,
and extracellular signal-regulated kinase 5 (ERK5) signaling.
Autophagy SGs had no functional pathways in AAA aorta.
Taken together, our results have demonstrated for the ﬁrst
time that ﬁrst, aortic cells in three cardiovascular metabolic
diseases such as atherosclerosis, CKD, and AAA modulate
different SGs for various pathophysiological functions and celltype speciﬁc functions (B cell signaling in caspase 4-GSDMD
secretome and T cell signaling in exosome secretome); second,
cell-type speciﬁc functions of caspase 4-GSDMD secretome is
atherosclerotic aortas-speciﬁc, which do not appear in CKD and
AAA aortas; third, exosome secretome carry out T cell signaling
function not only in atherosclerotic aortas but also in AAA
aortas STAT3 pathway (85) and PD-1, PD-L1 immune
checkpoint pathway (26, 57); fourth, autophagy secretome has
atherosclerotic functions of IL-27 and positive regulation of
response to external stimulus and does not play signiﬁcant
roles in CKD and AAA aortas; and ﬁfth, WPB secretome has
blood coagulation and platelet activation functions in
atherosclerotic aortas but has extracellular matrix functions
(NABA complexes) (84) in CKD aortas.

activation; and autophagy SGs for positive response to external
stimulus and regulation of protein kinase activity.
As shown in Figure 3B, canonical SGs in CKD aortas had
functional pathways, namely, MIF regulation of innate
immunity, triggering receptor expressed on myeloid cells 1
(TREM1) signaling, crosstalk between dendritic cells and
natural killer cells, integrin-linked kinase (ILK) signaling,
neuroinﬂammation signaling, cardiac hypertrophy signaling,
hepatic ﬁbrosis signaling, role of pattern recognition receptors
in recognition of bacteria and viruses, p38 mitogen-activated
protein kinase (MARK) signaling, and acute phase response
signaling. Caspase 1 SGs in CKD had functional pathways,
namely, senescence and autophagy, transmembrane receptor
protein serine/threonine kinase signaling, regulation of protein
containing complex assembly, neutrophil degranulation, and
response to wounding. Caspase 4 SGs in CKD had functional
pathways, namely, synaptogenesis signaling, leukocyte
extravasation, phospholipase C signaling, Fcg receptormediated phagocytosis in macrophages and monocytes, opioid
signaling, endothelin 1 signaling, hepatic ﬁbrosis signaling, IL-8
signaling, and neuroinﬂammation signaling. Exosome SGs in
CKD had functional pathways, namely, apelin pancreas
signaling, receptor tyrosine-protein kinase ErbB2 (human
epithelial growth factor receptor 2, HER-2)–receptor tyrosineprotein kinase erbB3 (HER-3) signaling, UVA induced MAPK
signaling, insulin receptor signaling, interferon signaling, cell
cycle control of chromosomal replication, granulocyte–
macrophage colony stimulation factor (GM-CSF) signaling,
stress activated protein kinase (SAPK)/Jun amino-terminal
kinase (JNK) signaling, serine/threonine protein kinase family
(PAK) signaling, and acute phase response signaling. Weibel–
Palate body SGs had NABA core matrisome, NABA ECM
glycoproteins (84), and skeletal system development. These
results have demonstrated that CKD modulate canonical SGs
for innate immunity and inﬂammation; caspase 1-GSDMD SGs
for senescence and response to wounding; caspase 4-GSDMD
SGs for leukocyte extravasation, inﬂammation, and ﬁbrosis;
exosome SGs for MAPK signaling, insulin receptor signaling;
Weibel–Palade body SGs for NABA complexes and skeletal
system. CKD did not signiﬁcantly modulate autophagy SGs.
As shown in Figure 3C, canonical SGs in AAA aortas had
functional pathways, namely, agrin interactions in
neuromuscular junction, ErbB signaling, cholecystokinin/
gastrin-mediated signaling, HER-2 signaling in breast cancer,
amyotrophic lateral sclerosis signaling, antioxidant action of
vitamin C, peroxisome proliferators activated receptors (PPAR)
signaling, semaphorin neuronal repulsive signaling, phosphatase
and tensin homolog deleted on chromosome 10 (PTEN)
signaling and PPARa/RXRa activation. Caspase 1 SGs in AAA
aortas had functional pathways, namely, positive regulation of
protein catabolic process, tissue homeostasis, viral life cycle,
ribonucleotide metabolic process, vascular endothelial growth
factor a (VEGFA)-VEGFR2 signaling, ribonucleoprotein
complex biogenesis, cellular component disassembly, and
positive regulation of ion transport. Caspase 4 SGs in AAA
had functional pathways, namely, Fcg receptor-mediated
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Canonical Secretome in Atherosclerotic
Aortas Upregulate Pattern Recognition
Receptors and Leukocyte Extravasation at
6 Weeks, T Cell Exhaustion and Fibrosis at
32 and 78 Weeks; Caspase 1, and
Caspase 4, Secretomes Have no
Functions at 6 Weeks, but Have Functions
of Cancer Metastasis, and NFAT Signaling
at 32 and 78 Weeks, Respectively; and
Exosome Secretome Has eNOS and
Calcium Signaling at 6 Weeks but GF-CSF
and NFAT Signaling at 32 and 78 Weeks
We then hypothesized that atherosclerotic aortas in different
time courses differentially modulate the expression of secretomic
genes. To test this hypothesis, we collected time courses
microarray datasets of atherosclerotic aortas at high fat feeding
for 6, 32, and 78 weeks, respectively, in Table 2. Canonical
secretomic genes at 6-week atherosclerotic aorta had functional
pathways, namely, reelin signaling in neurons, role of pattern
recognition receptors in recognition of bacteria and viruses,
glycoprotein VI (GP6) signaling, estrogen receptor signaling,
role of interferon-induced dsRNA-dependent protein kinase
(PKR) in interferon induction and antiviral response, factors
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TABLE 2 | Aortic secretomes are differentially modulated in different stages of atherosclerotic progression.
6 weeks
Canonical

32 weeks

Reelin Signaling in Neurons

Chondroitin Sulfate Degradation (Metazoa)

Role of Pattern Recognition Receptors in Recognition of
Bacteria and Viruses
GP6 Signaling Pathway
Estrogen Receptor Signaling
Role of PKR in Interferon Induction and Antiviral Response
Factors Promoting Cardiogenesis in Vertebrates
Leukocyte Extravasation Signaling

FAT10 Cancer Signaling Pathway

Osteoarthritis Pathway
Hepatic Fibrosis Signaling Pathway
Acute Phase Response Signaling
Caspase
1

T Cell Exhaustion Signaling Pathway
IL-6 Signaling
Toll-like Receptor Signaling
Hepatic Fibrosis Signaling Pathway
Role of IL-17F in Allergic Inﬂammatory Airway
Diseases
Neuroinﬂammation Signaling Pathway
TREM1 Signaling
Acute Phase Response Signaling
Integrin Signaling
Estrogen Receptor Signaling
Colorectal Cancer Metastasis Signaling

Caspase
4

ERK/MAPK Signaling
IL-8 Signaling
Neuroinﬂammation Signaling Pathway
Synaptogenesis Signaling Pathway
Fc Epsilon RI Signaling

Exosome

Melatonin Signaling

Role of PKR in Interferon Induction and
Antiviral Response
B Cell Receptor Signaling
Endothelin-1 Signaling
HOTAIR Regulatory Pathway
Systemic Lupus Erythematosus In B Cell
Signaling Pathway
GM-CSF Signaling
Role of NFAT in Regulation of the Immune
Response
FAT10 Cancer Signaling Pathway
Cell Cycle Control of Chromosomal
Replication
3-phosphoinositide Biosynthesis

Calcium Signaling
Synaptic Long Term Depression

PDGF Signaling
IL-8 Signaling

Apelin Cardiomyocyte Signaling Pathway
Cardiac Hypertrophy Signaling (Enhanced)
Endothelin-1 Signaling

TREM1 Signaling
PKCq Signaling in T Lymphocytes
Neuroinﬂammation Signaling Pathway

Reelin Signaling in Neurons
eNOS Signaling
Cholecystokinin/Gastrin-mediated Signaling
Cardiac Hypertrophy Signaling

78 weeks
D-myo-inositol (1,4,5,6)-Tetrakisphosphate
Biosynthesis
D-myo-inositol (3,4,5,6)-tetrakisphosphate
Biosynthesis
3-phosphoinositide Degradation
D-myo-inositol-5-phosphate Metabolism
3-phosphoinositide Biosynthesis
LPS/IL-1 Mediated Inhibition of RXR Function
Dendritic Cell Maturation
Toll-like Receptor Signaling
IL-6 Signaling
Acute Phase Response Signaling
Actin Nucleation by ARP-WASP Complex
Integrin Signaling
Synaptogenesis Signaling Pathway
Rac Signaling
Ephrin Receptor Signaling
Colorectal Cancer Metastasis Signaling
Role of NFAT in Regulation of the Immune
Response
B Cell Receptor Signaling
IL-8 Signaling
Neuroinﬂammation Signaling Pathway
Role of PKR in Interferon Induction and
Antiviral Response
Rac Signaling
fMLP Signaling in Neutrophils
Ephrin Receptor Signaling
Endothelin-1 Signaling
Systemic Lupus Erythematosus In B Cell
Signaling Pathway
Oncostatin M Signaling
PDGF Signaling
Type I Diabetes Mellitus Signaling
Role of NFAT in Regulation of the Immune
Response
Cell Cycle Control of Chromosomal
Replication
Th1 Pathway
Systemic Lupus Erythematosus In B Cell
Signaling Pathway
CD28 Signaling in T Helper Cells
Neuroinﬂammation Signaling Pathway
PKCq Signaling in T Lymphocytes

IPA analysis of modulated genes in different time course (6 weeks, 32 weeks, and 78 weeks) of aorta in atherosclerosis (GSE10000). Z score>1.

metabolic signaling pathways such as D-myo-inositol (1,4,5,6)tetrakisphosphate biosynthesis, D-myo-inositol (3,4,5,6)tetrakisphosphate biosynthesis, 3-phosphinositide degradation,
D-myo-inositol-5-phosphate biosynthesis metabolism, 3phosphinositide biosynthesis, and ﬁve inﬂammatory signaling
pathways such as LPS/IL-1 mediated inhibition of RXR function,
dendritic cell maturation, Toll-like receptor signaling, IL-6
signaling and acute phase response signaling. These results
have demonstrated that ﬁrst, atherosclerotic aorta cells
differentially modulate the expression of canonical secretomic
genes in the three time points; second, at 6 weeks atherosclerotic

promoting cardiogenesis, leukocyte extravasation signaling,
osteoarthritis pathway, hepatic ﬁbrosis signaling, and acute
phase response signaling. Canonical secretomic genes at 32
weeks atherosclerotic aorta had functional pathways, namely,
chondroitin sulfate degradation, ubiquitin-like modiﬁer FAT10
cancer signaling, T cell exhaustion signaling, IL-6 signaling, Tolllike receptor signaling, hepatic ﬁbrosis signaling, role of IL-17F
in allergic inﬂammatory airway disease, neuroinﬂammation
signaling, TREM1 signaling, and acute phase response
signaling. Canonical secretomic genes at 78 weeks
atherosclerotic aorta had functional pathways, namely, ﬁve
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correct neuronal positioning) signaling, EC nitric oxide
synthase (eNOS) signaling, cholecystokinin/gastrin-mediated
signaling, cardiac hypertrophy signaling, melatonin signaling,
calcium signaling, synaptic long-term depression, apelin
cardiomyocyte signaling, cardiac hypertrophy signaling and
endo thelin-1 signali ng. Exo some SGs at 32 weeks
atherosclerotic aortas had functional pathways, namely,
granulocyte–macrophage colony stimulating factor (GM-CSF)
signaling, role of NFAT in regulation of immune response, HLAF-adjacent transcript 10 (FAT10, an ubiquitin-like modiﬁer)
cancer signaling, cell cycle control of chromosomal replication,
3-phophoinositide biosynthesis, PDGF signaling, IL-8 signaling,
TREM1 signaling, protein kinase Cq (PKCq) signaling in T cells,
and neuroinﬂammation signaling. Exosome SGs at 78 weeks
atherosclerotic aortas had functional pathways, namely,
oncostatin M signaling, PDGF signaling, type-I diabetes
signaling, role of NFAT in regulation of immune response, cell
cycle control of chromosomal replication, Th1 pathway, systemic
lupus erythematosus in B cell signaling, CD28 signaling in T
helper cells, neuroinﬂammation signaling and PKCq signaling in
T cells.
These results have demonstrated that ﬁrst, exosome SGs at 6
weeks atherosclerotic aortas have pathophysiological functional
pathways such as eNOS, cardiac hypertrophy, endothelin-1
signaling; second, starting from 32 to 78 weeks, exosome SGs
in atherosclerotic aortas have ﬁve functional pathways in
common, namely, role of NFAT in regulation of immune
response, cell cycle control of chromosomal replication, PDGF
signaling, neuroinﬂammation signaling and PKCq signaling in T
cells; third, at 32 weeks exosome SGs in atherosclerotic aortas
have several speciﬁc functional pathways, namely, GM-CSF,
FAT10 cancer signaling, 3-phosphoinositide biosynthesis, IL-8,
and TREM1 signaling; whereas at 78 weeks exosome SGs in
atherosclerotic aortas have ﬁve speciﬁc functional pathways,
namely, oncostatin M, type-I diabetes, Th1 pathway, systemic
lupus erythematosus in B cell signaling, and CD28 signaling in T
helper cells.

aortas have more role of pattern recognition receptors, interferon
induction and leukocyte extravasation signaling; 32 weeks
atherosclerotic aortas have more T cell exhaustion, IL-6
signaling and neuroinﬂammation signaling; 78 weeks
atherosclerotic aortas have more metabolic reprogramming,
LPS/IL-1 inhibition of RXR function, dendritic cell maturation,
and Toll-like receptor (TLR) signaling.
Caspase 1-GSDMD SGs at 6 weeks atherosclerotic aortas had no
functional pathways. However, at 32 weeks had three functional
pathways, namely, integrin signaling, estrogen receptor signaling,
and colorectal cancer metastasis signaling and at 78 weeks
atherosclerotic aortas had six functional pathways, namely actin
nucleation by ARP–WASP complex, integrin signaling,
synaptogenesis signaling, Rac signaling, ephrin receptor signaling,
and colorectal cancer metastasis signaling. These results have
demonstrated that ﬁrst, at as early as 6 weeks, atherosclerotic
aortas have no functional caspase 1-GSDMD secretomic
functions; second, starting from 32 to 78 weeks, atherosclerotic
aortas have two major functional pathways, namely, integrin
signaling and colorectal cancer metastasis signaling; third,
estrogen receptor signaling only appears in 32 weeks
atherosclerotic aortas whereas four functional pathways appear
only in 78 weeks atherosclerotic aortas, namely, actin nucleation
by ARP–WASP complex, synaptogenesis signaling, Rac signaling,
and ephrin receptor signaling.
Caspase 4 SGs at 6 weeks atherosclerotic aortas had no
functional pathways, however, at 32 weeks had functional
pathways, namely, ERK/MAPK signaling, IL-8 signaling,
neuroinﬂammation, synaptogenesis, Fc epsilon RI, role of PKR
in interferon induction and antiviral response, B cell receptor
signaling, endothelin-1 signaling, HOTAIR (a long non-coding
RNA) signaling, and systemic lupus erythematosus in B cell
signaling. Caspase 4 SGs at 78 weeks atherosclerotic aortas had
functional pathways, namely, role of NFAT in regulation of
immune response, B cell receptor signaling, IL-8 signaling,
neuroinﬂammation, role of PKR in interferon induction and
antiviral response, Rac (a member of small GTPase family)
signaling, formyl peptide receptor 1 (fMLP) signaling in
neutrophils, ephrin receptor signaling, endothelin-1 signaling,
and systemic lupus erythematosus in B cell signaling. These
results have demonstrated that ﬁrst, at as early as 6 weeks,
atherosclerotic aortas have no functional caspase 4-GSDMD
secretomic functions; second, starting from 32 to 78 weeks,
atherosclerotic aortas have six functional pathways such as IL-8
signaling, neuroinﬂammation, B cell receptor signaling,
endothelin-1 signaling, role of PKR in interferon induction and
antiviral response and systemic lupus erythematosus in B cell
signaling; third, four functional pathways appear only at 32 weeks
atherosclerotic aortas, namely, ERK/MAPK, synaptogenesis, Fc
epsilon RI, HOTAIR regulatory pathway whereas four other
functional pathways appear only at 78 weeks atherosclerotic
aortas such as role of NFAT in regulation of immune response,
Rac signaling, fMLP signaling in neutrophils, and ephrin
receptor signaling.
Exosome SGs at 6 weeks atherosclerotic aortas had functional
pathways, namely, Reelin (a large, secreted glycoprotein for
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Ang II-Induced AAA, Canonical, Caspase
4, and Exosome Secretomes Have Two
Peaks of High (Day 7)-Low (Day 14)-High
(Day 28) Expression Patterns; Caspase 1,
WPB, and Autophagy Secretomes Are
Only Functional at Day 7; and the Early
Secretomes May Function as Drivers for
Trained Immunity and Sustained
Inﬂammation
We then hypothesized that abdominal aortic aneurysm aortas in
different time courses differentially modulate the expression of
secretomic genes. To test this hypothesis, we collected time
courses microarray datasets of aneurysm aortas at days 7, 14,
and 28. As shown in Figure 4A, at day 7, AAA aortas
upregulated 402 canonical SGs, 41 caspase 1 SGs, 96 caspase 4
SGs, 730 exosome SGs, 15 WPB SGs and 4 autophagy SGs. At
day 14, AAA aortas upregulated 120 canonical SGs, 5 caspase 1
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A
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FIGURE 4 | Ang-II induced AAA, canonical, caspase 4, and exosome SGs in aortas have two expression peaks of high (Day 7)-low (Day 14)-high (Day 28) patterns
suggesting the evidence of trained immunity response. (A) Canonical, caspase 4-GSDMD, and exosome pathways have two peak (three-phase) of high (Day 7)-low
(Day 14)-high (Day 28) patterns; and caspase 1-GSDMD, Weibel-Palade body, and autophagy secretomes are only functional at the Day 7 AAA aortas. P < 0.05,
LogFC>1 or < -1. (B) The signal pathways of secretomic genes are different in AAA progression. Z score>1.

tumor microenvironment pathway, and systemic lupus
erythematosus in B cell signaling. Canonical secretomic genes
in day 14 AAA aortas had functional pathways, namely,
dendritic cell maturation, HMGB1 signaling, IL-6 signaling,
neuroprotective role of THOP1 in Alzheimer’s disease, vitamin
D receptor (VDR)/RXR activation, cardiac hypertrophy
signaling, intrinsic prothrombin activation pathway,
synaptogenesis signaling, apelin liver signaling, and GP6
signaling. Canonical secretomic genes in day 28 AAA aortas
had functional pathways, namely, acute phase response
signaling, inhibition of AU-rich elements (AREs)-mediated
mRNA degradation, T cell exhaustion signaling, HOTAIR

SGs, 8 caspase 4 SGs, 132 exosome SGs, 4 WPB SGs, and 1
autophagy SG. At day 28, AAA aortas upregulated 119 canonical
SGs, 10 caspase 1 SGs, 37 caspase 4 SGs, 241 exosome SGs, 4
WPB SGs, and 1 autophagy SG.
We then examined AAA modulated secretomic gene
functions by performing Ingenuity Pathway Analysis (IPA). As
shown in Figure 4B, canonical secretomic genes in day 7 AAA
aortas had functional pathways, namely, IL-17 signaling, p38
MAPK signaling, cardiac hypertrophy signaling, role of
hypercytokinemia/hyperchemokinemia in the pathogenesis of
inﬂuenza, TREM1 signaling, HOTAIR pathway, high mobility
group box 1 (HMGB1) signaling, dendritic cell maturation,
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activation, endocannabinoid cancer inhibition pathway, PTEN
signaling, role of hypercytokinemia/hyperchemokinemia in
pathogenesis of inﬂuenza, role of PKR interferon induction
and antiviral response, role of p14/p19ARF in tumor
suppression, neuroprotective role of THOP1 in Alzheimer’s
disease, and RHOGDI signaling. Exosome SGs at the day 14
AAA aortas had functional pathways, namely, role of
hypercytokinemia/hyperchemokinemia in pathogenesis of
inﬂuenza, cell cycle control of chromosomal replication,
hepatic ﬁbrosis signaling, regulation of actin-based motility by
Rho, Th1 pathway, Fcg (antibody Fc fragment) receptormediated phagocytosis in macrophages and monocytes, GP6
signaling, TEC kinase signaling, neuroinﬂammation signaling
and phagosome formation. These results have demonstrated that
ﬁrst, at all three time points one functional pathway, role of
hypercytokinemia/hyperchemokinemia in pathogenesis of
inﬂuenza, is shared; second, four functional pathways are
shared by the day 7 AAA aortas and day 28 AAA aortas,
namely, phagosome formation, regulation of actin-based
motility by Rho, cell cycle control of chromosomal replication,
and hepatic ﬁbrosis signaling; third, one functional pathway of
neuroprotective role of THOP1 in Alzheimer’s disease is shared
by the day 7 and day 14 AAA aortas; and fourth, exosome SGs in
AAA aortas have time point-speciﬁc functions.
WPB SGs at the day 7 AAA aortas had one functional
pathway, hepatic ﬁbrosis signaling. Autophagy SGs at the day
7 AAA aortas had ﬁve functional pathways, namely,
neuroinﬂammation signaling, HMGB1 signaling, IL-17
signaling, systemic lupus erythematosus in B cell signaling,
cardiac hypertrophy signaling.
Taken together, our results have demonstrated that ﬁrst,
among six secretomic pathways in Ang-II induced abdominal
aortic aneurysm aortas, canonical, caspase 4, and exosome
pathways all have two peak (three-phase) of high (day 7)-low
(day 14)-high (day 28) expression patterns; second, caspase 1,
WPB and autophagy secretomes are only function at the day 7;
and third, the early secretomes may function as drivers for
trained immunity (52, 59, 65) and sustained inﬂammation (51).

pathway, tumor microenvironment pathway, IL-17 signaling,
systemic lupus erythematosus in B cell signaling, dendritic cell
maturation, cardiac hypertrophy signaling, and hepatic ﬁbrosis
signaling. These results have demonstrated that ﬁrst, each time
point, AAA aortas have their own speciﬁc canonical secretomic
signaling pathways; second, two pathways are shared in all three
time points, namely, cardiac hypertrophy signaling, dendritic cell
maturation; one pathway is shared in the day 7 AAA aortas and
the day 14 AAA aortas, HMGB1; whereas as many as
four pathways are shared by the day 7 AAA aortas and the
day 28 AAA aortas, namely, HOTAIR pathway, tumor
microenvironment pathway, IL-17 signaling and systemic
lupus erythematosus in B cell signaling; and third, these
ﬁndings suggest that AAA aortas have two-peak signaling
processes in the pathogenesis of AAA.
Caspase 1 SGs at day 7 AAA aortas had functional pathways,
namely, epithelial adherens junction signaling, integrin signaling,
estrogen receptor signaling, phagosome formation, Fcg receptormediated phagocytosis in macrophages and monocytes, actin
cytoskeleton signaling, and insulin secretion signaling. However,
caspase 1 SGs at the day 14 AAA aortas and the day 28 AAA
aortas have no signiﬁcant functional pathways.
Caspase 4 SGs at the day 7 AAA aortas had functional
pathways, namely, actin nucleation by ARP-WASP complex,
phospholipase C signaling, RAC signaling, TEK tyrosine kinase
signaling, Fcg receptor-mediated phagocytosis in macrophages
and monocytes, IL-8 signaling, actin cytoskeleton signaling,
regulation of actin-based motility by Rho, signaling by Rho
family GTPase, and phagosome formation. Caspase 4 SGs at
the day 14 AAA aortas had functional pathways of endothelin-1
signaling. Caspase 4 SGs at the day 28 AAA aortas had functional
pathways, namely, ephrin receptor signaling, type-1 diabetes
signaling, role of NFAT in regulation of immune response,
phagosome formation, Fcg receptor-mediated phagocytosis in
macrophages and monocytes, IL-15 signaling, p70S6K signaling,
leukocyte extravasation signaling, role of PKR in interferon
induction and antiviral response, and endothelin-1 signaling.
These results have demonstrated that ﬁrst, once again, caspase 4
SGs at the days 7 and 28 but not day 14 AAA aortas have twopeak signaling processes in the pathogenesis of AAA; second, the
caspase 4 SGs in the day 14 AAA aortas have only one functional
pathway; and third, the caspase 4 SGs in the day 7 and day 28
AAA aortas share two functional pathways, namely, Fcg
receptor-mediated phagocytosis in macrophages and
monocytes and phagosome formation.
Exosome SGs at the day 7 AAA aortas had functional
pathways, namely, neuroprotective role of THOP1 in
Alzheimer’s disease, regulation of actin-based motility by Rho,
osteoarthritis pathway, phagosome formation, TREM1 signaling,
HIPPO (an evolutionarily conserved serine/threonine kinase)
signaling, hepatic ﬁbrosis signaling, role of hypercytokinemia/
hyperchemokinemia in pathogenesis of inﬂuenza, cell cycle
control of chromosomal replication, and EIF2 signaling.
Exosome SGs at the day 14 AAA aortas had functional
pathways, namely, superpathway of cholesterol biosynthesis,
PD-1, PD-L1 cancer immunotherapy, intrinsic prothrombin
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Elastase Induced AAA Have More
Inﬂammatory and Immune Pathways Than
That of Ang-II Induced AAA
Ang-II induced, elastase induced, and calcium chloride/phosphate
induced AAA are three commonly used mouse models (86) in
addition to a few surgical mouse models (87) for the induction of
AAA. We then hypothesized that elastase induced AAA aortas
differentially modulate the expression of secretomic genes from that
of Ang-II AAA aortas. To test this hypothesis, we collected elastase
induced AAA microarray datasets (GSE51299) (Figure 5A). Of
note, we could not ﬁnd microarray datasets for calcium chloride/
phosphate-induced AAA for our analyses. Of note, the data in
Figure 4A showed that Ang-II induced AAA (28 days) upregulated
4.51% canonical secretome, 1.04% caspase 1 secretome, 3.03%
caspase 4 secretome, 3.67% exosome secretome, 10.81% WPB
secretome, and 6.25% autophagy secretome, respectively. In
contrast, in Figure 5A, elastase induced AAA upregulated 13.67%
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FIGURE 5 | Elastase induced AAA aortas have more inﬂammatory/immune pathways than that of Ang-II induced AAA aortas. (A) The signal pathways of secretomic
genes are different in AAA progression. P < 0.05, |LogFC|>1. (B) IPA analysis of elastase induced AAA (GSE51229) in each secretory pathway. Z score>1. (C) The
Venn diagram of upregulated pathways in Day 7 Ang II induced AAA and elastase induced AAA. Z score>1 .

signaling, Fc epsilon RI signaling, synaptogenesis signaling, fMLP
signaling in neutrophils, RAC signaling, Reelin signaling in neurons,
IL-8 signaling, endothelin-1 signaling, ephrin receptor signaling,
and tumor microenvironment pathway. Exosome SGs in elastase
induced AAA aortas had functional pathways, namely, CD28
signaling in T helper cells, interferon signaling, inducible nitric
oxide synthase (iNOS) signaling, role of NFAT in regulation of
immune response, regulation of IL-2 expression in activated and
anergic T cells, Th1 pathway, systemic lupus erythematosus in B cell
signaling, role of hypercytokinemia/hyperchemokinemia, T cell
receptor signaling, and protein kinase C q (PKCq) signaling in T
cells. WPB SGs in elastase induced AAA aortas had no signiﬁcant
functional pathways. Autophagy SGs in elastase induced AAA
aortas had functional pathways, namely, neuroinﬂammation
signaling, high mobility group box 1 (HMGB1) signaling, IL-17
signaling, systemic lupus erythematosus in B cell signaling, and
cardiac hypertrophy signaling.
In addition, we determined whether elastase induced AAA
shared SG pathways with that of Ang-II induced AAA. As shown
in Figure 5C, elastase induced AAA shared six top canonical SG
pathways with that of Ang-II induced AAA, namely, tumor
microenvironment pathway, TREM1 signaling, role of
hypercytokenemia/hyperchemokinemia in the pathogenesis of
inﬂuenza, systemic lupus erythematosus in B cell signaling,
dendritic cell maturation, and IL-17 signaling. Elastase induced
AAA shared 0 top caspase 1 SGs with that of Ang-II induced
AAA. Elastase induced AAA shared two top caspase 4 SG
pathways with that of Ang-II induced AAA such as IL-8

canonical SGs (3.03 folds higher than that of Ang-II induced AAA),
3.84% caspase 1 SGs (3.69 folds higher than that of Ang-II induced
AAA), 7.60% caspase 4 SGs (2.51 folds higher than that of Ang-II
induced AAA), 10.99% exosome SGs (2.99 folds higher than that of
Ang-II induced AAA), 21.62% WPB SGs (2.0 folds higher than that
of Ang-II induced AAA) and 25.0% autophagy SGs (4.0 folds higher
than that of Ang-II induced AAA), respectively, suggesting that
elastase induced AAA upregulations of SGs were much more that of
Ang-II induced AAA; and that elastase induced AAA can be much
more inﬂammatory than that of Ang-II induced AAA. Of note, the
results need to be further consolidated with additional experiments
with side-by-side two model comparisons. As shown in Figure 5B,
canonical SGs in elastase induced AAA aortas had functional
pathways of IL-17 signaling, differential regulation of cytokine
production by IL-17A and IL-17F, IL-6 signaling, tumor
microenvironment pathway, acute phase response, TREM1
signaling, systemic lupus erythematosus in B cell signaling,
crosstalk between dendritic cells and natural killer cells, role of
hypercytokinemia/hyperchemokinemia, and dendritic cell
maturation. Caspase 1-GSDMD SGs in elastase induced AAA
aortas had functional pathways, namely, systemic lupus
erythematosus in T cell signaling, breast cancer regulation by
strathmin1, synaptogenesis signaling, actin nucleation by ARPWASP complex, RAC signaling, IL-8 signaling, tumor
microenvironment pathway, systemic lupus erythematosus in B
cell signaling, ephrin receptor signaling, and colorectal cancer
metastasis signaling. Caspase 4 SGs in elastase induced AAA
aortas had functional pathways of amyotrophic lateral sclerosis
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cytokines/interactors were upregulated in exosome secretome,
two cytokines/interactors were upregulated in WBP, and one
cytokine/interactor was upregulated in autophagy.
Taken together, these results have demonstrated that 1) most
IPA designated cytokines, chemokines and interactors are
secreted via canonical (39/56 = 69.6%) and exosome (14/56 =
25%) SG pathways in atherosclerotic aorta; 2) most IPA
designated cytokines, chemokines and interactors are secreted
via canonical (14/25 = 56%) and exosome (10/25 = 40%) SG
pathways in CKD aorta; 3) most IPA designated cytokines,
chemokines and interactors are secreted via canonical (10/13 =
76.9%) and exosome (3/13 = 23%) SG pathways in AAA aorta; 4)
no much cytokines, chemokines and interactors are secreted via
caspase 1, and caspase 4 secretomes in those three aortic diseases;
and 5) most of disease upregulated cytokines, chemokines and
interactors in aorta are disease-speciﬁc.

signaling and RAC signaling. Elastase induced AAA shared one
top exosome SG pathway with that of Ang-II induced AAA in
role of hypercytokenemia/hyperchemokinemia in the
pathogenesis of inﬂuenza. Elastase induced AAA shared ﬁve
top autophagic SG pathways with that of Ang-II induced AAA,
namely, cardiac hypertrophy, systemic lupus erythematosus in B
cell signaling, neuroinﬂammation signaling, HMGB1 signaling,
and IL-17 signaling.
Taken together, our results have demonstrated that ﬁrst,
elastase induced AAA aortas have more inﬂammatory and
immune pathways than that of Ang-II induced AAA aortas.
For example, elastase induced AAA aortas have IL-17, IL8, IL-6,
T cell pathways and B cell pathways in various secretomes, which
are well correlated with inﬂammation, inﬂux of T cells to the
aorta, upregulation of cytokines, and recruitment of leukocytes
reported for elastase induced AAA mouse model (86); second,
elastase induced AAA aortas have caspase 1 secretome and
caspase 4 secretome with more T cell and B cell pathways,
which are not found in atherosclerosis aortas, CKD aortas, and
Ang-II induced AAA aortas; third, Elastase induced AAA shared
0 caspase 1 SG pathways with that of Ang-II induced AAA; and
fourth, among the ﬁve secretomes examined, four secretomes
such as canonical, caspase 1, caspase 4, exosome secretomes are
signiﬁcantly different in Ang-II induced AAA and elastase
induced AAA.

Canonical and Caspase 1 Secretome Play
Roles at Early MERS-CoV (COVID19
Homologous Virus) Infection Whereas
Caspase 4 and Exosome Secretome Play
Roles in the Chronic Phase Infection; and
the Early Upregulated Canonical and
Caspase 1 Secretomes may Function as
Drivers for Trained Immunity
Our previous report showed that large numbers of innate
immune genes were modulated in human microvascular EC
(HMECs) stimulated with wild-type MERS-CoV, a virus
homologous to COVID-19 (35). However, canonical and
noncanonical secretomic changes in HMECs infected with
MERS-CoV remained unknown. As shown in Figures 6A, B,
MERS-CoV infection of HMECs resulted in upregulation of 5.72,
8.83, 8.75, and 4.55% of canonical SGs at 12-, 24-, 36-, and 48-h
post-infection, respectively. MERS-CoV infection of HMECs
resulted in upregulation of 0.73, 2.7, 2.7, and 4.46% of caspase
1 SGs at 12-, 24-, 36-, and 48-h post-infection, respectively.
MERS-CoV infection of HMECs resulted in upregulation of 1.55,
3.84, 4.5, and 4.99% of caspase 4 SGs at 12-, 24-, 36-, and 48-h
post-infection, respectively. MERS-CoV infection of HMECs
resulted in upregulation of 5.24, 10.75, 10.12, and 9.39% of
exosome SGs at 12-, 24-, 36-, and 48-h post-infection,
respectively. MERS-CoV infection of HMECs resulted in
upregulation of 5.41, 8.11, 5.41, and 5.41% of WPB SGs at 12-,
24-, 36-, and 48-h post-infection, respectively. MERS-CoV
infection of HMECs resulted in upregulation of 6.25, 6.25,
6.25, and 6.25% of autophagy SGs at 12-, 24-, 36-, and 48-h
post-infection, respectively. In addition, as shown in Figure 6C,
at 48 h post-infection, the SG modulation percentages were
signiﬁcantly increased in caspase 1, caspase 4, exosome, and
autophagy secretomes but not canonical secretome, which were
only increased in 12 h post-infection. Upregulated SG
percentages in each group were similar in 12-, 24- and 36-h
post-infection (Figures 6D, E). Canonical and caspase 1 SGs
were upregulated at early time points but decreased at 36 h postinfection whereas exosome SGs and caspase 4 SGs were
signiﬁcantly increased starting from 36 h, suggesting that

Most Disease-Upregulated Cytokines and
Chemokines in Aorta Are Secreted via
Canonical and Exosome Secretomes but
not Caspase 1 and Caspase 4 Secretomes
Before caspase 1 secretome was reported in 2008 (61), it was been
widely believed that most characterized cytokines and chemokines
are secreted via canonical secretory pathway. However, it remains
unknown that in mouse aortas affected by metabolic
cardiovascular diseases whether well characterized cytokines and
chemokines are all secreted via canonical secretory pathway. To
examine this issue, we used the Ingenuity Pathway Analysis (IPA)
designed list of 1,176 cytokines, chemokines and their interactors
(https://www.proteinatlas.org/search/cytokine) as we reported
(27). As shown in Table 3, in atherosclerotic aorta, 39
cytokines/interactors were upregulated in canonical secretome,
no cytokines/interactors were upregulated in caspase 1 secretome,
three cytokines/interactors were upregulated in caspase 4
secretome, 14 cytokines/interactors were upregulated in exosome
secretome, one cytokine/interactor was upregulated in WBP, and
three cytokines/interactors were upregulated in autophagy. In
CKD aorta, 14 cytokines/interactors were upregulated in
canonical secretome, no cytokines/interactors were upregulated
in caspase 1 secretome, one cytokine/interactor was upregulated in
caspase 4 secretome, 10 cytokines/interactors were upregulated in
exosome secretome, no cytokines/interactors were upregulated
in WBP, and two cytokines/interactors were upregulated in
autophagy. In AAA, 10 cytokines/interactors were upregulated
in canonical secretome, no cytokines/interactors were
upregulated in caspase 1 secretome, no cytokines/interactors
were upregulated in caspase 4 secretome, three
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immune organ in pathological conditions; and 4) SG
upregulation in MERS-CoV infected HMECs may contribute
signiﬁcantly to cytokine storm, thrombosis and CVD related to
COVID-19 infection (35).

canonical and caspase 1 secretomes play more roles at early
MERS-CoV infection of HMECs whereas caspase 4 and exosome
secretomes play more roles in the late and chronic phase
infection. These results suggested novel therapeutic targets.
The IPA analysis results of upregulated SGs in MERS-CoVinfected HMECs showed that the ten top pathways for each
secretome were different, suggesting that during MERS-CoV
infection of ECs, secretomes play their speciﬁc roles in secrete
functional regulators (Figure 6F), which may serve as a potential
mechanism underlying the pathogenesis of cytokine storm, EC
dysfunction (28), immunothrombosis (88) and cardiovascular
inﬂammation (89) in COVID-19 infection (35). Canonical SGs
in MERS infection had different metabolic and inﬂammatory
functional pathways, namely, D-myo-inositol 5-phosphate
metabolism, 3-phosphoinsitide biosynthesis, thyroid cancer
signaling, TREM1 signaling, super pathway of inositol
phosphate compounds, bladder cancer signaling, roles of IL17F in allergic inﬂammatory airway diseases, IL-23 signaling
pathway, FGF signaling, and Th17 activation pathway.
Canonical SGs in CKD had inﬂammatory functional pathways,
namely, MIF regulation of innate immunity, TREM1 signaling,
crosstalk between dendritic cells and natural killer cells, ILK
signaling, neuroinﬂammation signaling, cardiac hypertrophy,
hepatic ﬁbrosis signaling, role of pattern recognition receptors,
p38 MAPK signaling, and acute phase response signaling.
Canonical SGs in AAA had less inﬂammatory but more
neurosignaling, namely, agrin interactions at neuromuscular
junction, ErbB signling, cholecystokinin/gastrin-mediated
signaling, Her-2 signaling in breast cancer, amyotrophic lateral
sclerosis signaling, antioxidant action of vitamin C, PPAR
signalin, semaphoring neuronal repulsive signaling, PTEN
signaling, and PPARa/RXRa activation.
In addition, we hypothesized that each disease uses several
types of SGs for different functions. For example, as shown in
Figure 3A, atherosclerosis had caspase 1 secretome for the
functional pathways, namely, actin cytoskeleton signaling,
leukocyte extravasation signaling, estrogen receptor signaling,
actin nucleation by ARP–WASP complex, integrin signaling,
synaptogenesis signaling, Rac signaling, Ephrin receptor
signaling and colorectal cancer metastasis signaling. In
addition, atherosclerosis had caspase 4 secretome for
inﬂammation and B cell signaling, namely, roles of NFAT in
regulation of immune response, B cell receptor, IL-8 signaling,
neuroinﬂammation, role of PKR in interferon induction and
antiviral response, Rac signaling, fMLP signaling, Ephrin
receptor, endothelin-1 signaling, and systemic lupus
erythematosus in B cell signaling.
Taken together, these results have demonstrated that 1)
canonical and caspase 1 secretomes play more roles at early
MERS-CoV infection of HMECs whereas caspase 4 and exosome
secretomes play more roles in the late and chronic phase
infection; 2) early secretomes, namely, canonical and caspase 1
secretomes may promote inﬂammation effectors (2), trained
immunity (enhancing sustained/chronic inﬂammation and
trained tolerance (inﬂammation resolution) (32, 65); 3) since
ECs are one of the largest organs in the body (32), ECs are an
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Venous ECs From Arteriovenous Fistula
(AVF) Upregulates Genes in Five
Secretomes, Resulting in Two Pathways in
Canonical Secretome and 13 Pathways in
Exosome Secretome; AVF Secretomes
Have One Canonical and Five Exosome
Pathways Unique; AVF Secretomes Share
Pathways With That of Atherosclerosis
Aorta, CKD Aorta, MERS-CoV Infected
ECs, But Not With That of Ang-II Induced
AAA Aorta
Vascular shear stress results from ﬂowing blood generated
frictional force, which has major effects on vascular function.
Complex blood ﬂow patterns exert low or low oscillatory shear
stress at branches and bends of arteries, this mechanical
environment promotes vascular dysfunction and atherosclerosis
(90). A signiﬁcant rise of end-stage renal disease (21) in the world
has resulted in increased placement of autogenous arteriovenous
ﬁstula (AVF) as the preferred type of vascular access for
maintenance hemodialysis (91). Up to 60% of AVF fail to
mature by 5 months, preventing their use for hemodialysis. The
failed AVF deﬁned by updated NKF-KDOQI guidelines (92) may
result from shear stress in new branch and bend of
artery-connected vein, changes of blood ﬂow direction and
arterial blood pressure actin on vascular wall (Figure 7A),
inﬂammation, and inappropriate venous inward and outward
remodelings (20), contributing to stenosis, access failure,
signiﬁcant patient burden and healthcare cost (93). RNA-Seq
data identiﬁed that in AVF, gene expressions associated with
inﬂammation, TGF-b; and cell death pathways are signiﬁcantly
modulated (94). Fractalkine receptor 1 (C-X3-C motif chemokine
receptor 1, CX3CR1) blockade reduces venous neointimal
hyperplasia (VNH)/venous stenosis (VS) formation in stenotic
AVF samples by decreasing proinﬂammatory cues (95). However,
inﬂammation related secretomes in AVF remain poorly
characterized. We hypothesized that AVF injury signiﬁcantly
modulates secretomic gene expressions. To test this hypothesis,
we examined the SG expression changes in venous ECs isolated
during the formation of neointimal hyperplasia in a rat ATF
model for kidney dialysis GEO database (GSE46126). As shown in
Figure 7B, AVF upregulated 0.95% canonical secretome, 0.83%
caspase 1 secretome, 0.90% caspase 4 secretome, 1.25% exosome
secretome, 8.11% WPB secretome, and 0% autophagy secretome.
The pathway analysis indicated that AVF canonical secretome had
two functional pathways, namely, pulmonary ﬁbrosis idiopathic
signaling and hepatic ﬁbrosis signaling; AVF exosome secretome
had 13 functional pathways, namely, signaling by Rho family
GTPases, hepatic ﬁbrosis signaling, RHOA signaling, integrin
signaling, pulmonary ﬁbrosis idiopathic signaling, regulation of
actin-based motility by Rho, IL-8 signaling, CDC42 signaling,
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TABLE 3 | Most disease-upregulated cytokines from total 1176 genes in aortas are secreted via canonical and exosome secretory pathways but not caspase-1-,
caspase-4-GSDMD secretory pathways.

AS
MERS
AAA
CKD
Fistula

Canonical

Caspase 1

Caspase 4

Exosome

WPB

Autophagy

39
25
10
14
6

0
5
0
0
0

3
6
0
1
2

14
52
3
10
11

1
0
2
0
0

3
1
1
2
0

Numbers of upregulated cytokines in different disease conditions in each secretory pathway. Cytokine get from IPA analysis. P<0.05, LogFC>0.
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B
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D

E
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FIGURE 6 | Canonical secretome and caspase 1 secretome play more roles at early MERS-CoV (COVID-19 homoglous virus) infection of human microvascular
endothelial cells whereas caspase 4 secretome and exosome secretome play more roles in the late and chronic phase infection; and these results have suggested
novel therapeutic targets. (A) Canonical secretion and exosomes are most important secretory pathways in MERS condition. Number of differentially modulated
genes in each pathway. P <0.05, |LogFC|>1. (B) MERS 36 hour is a transition time point in this process. Number of pathways which are regulated in MERS
condition. (|Z score|>1 ). (C) Percentage of up/down gene number in each group based on (A). (D) Percentage of upregulated genes in each group. (E) Percentage
of upregulated pathways in each group based on (B). (F) IPA analysis of upregulated genes in each group. Top 10 pathways are shown. Z score>1.
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FIGURE 7 | Venous ECs from arteriovenous ﬁstula (AVF) upregulate SGs in ﬁve secretomes. (A) Experimental model of AVF with vascular anatomy (Red and Blue)
and pathologic factors (Black). (B) Secretome analysis of venous endothelium during the formation of neointimal hyperplasia in a rat AVF model for kidney dialysis
from GEO database (GSE46126) P <0.05 |LogFC|>1. (C) IPA analysis of each secretory pathway gene in AVF. Z score>1. (D, E) Venn diagram of upregulated
canonical (D) and exosome (E) pathways in AVF.

pathways and ﬁve unique exosome pathways; and 4) AVFvenous ECs SGs share two pathways with that of
atherosclerotic aorta and CKD aorta; ﬁve pathways with
MERS-CoV infected ECs, but share no any pathways with that
of Ang-II induced AAA.

EIF2 signaling, actin cytoskeleton signaling, synaptogenesis
signaling, estrogen receptor signaling and cardiac hypertrophy
signaling (Figure 7C). The Venn Diagram analysis showed that
AVF canonical SGs had a unique pathway, pulmonary ﬁbrosis
idiopathic signaling; AVF canonical SGs had hepatic ﬁbrosis
signaling pathway shared with that of atherosclerotic aorta and
CKD aorta; and AVF canonical SGs had no shared pathways with
AAA aorta and MERS-CoV infected ECs (Figure 7D). In
addition, AVF exosome SGs had ﬁve unique functional
pathways such as synaptogenesis signaling, RHOA signaling,
estrogen receptor signaling, pulmonary ﬁbrosis idiopathic
signaling, and CDC42 signaling; AVF exosome secretome had
two pathways such as IL-8 signaling and hepatic ﬁbrosis signaling
shared with that of atherosclerosis aorta and CKD aorta; AVF
exosome SGs had one pathway, actin cytoskeleton signaling
shared with that of CKD aorta and MERS-CoV infected ECs;
AVF exosome SGs had ﬁve pathways shared with MERS-CoV
infected ECs, namely, Rho family GTPases, cardiac hypertrophy
signaling, EIF2 signaling, regulation of actin-based motility by
Rho, and integrin signaling (Figure 7E); and AVF exosome had no
overlapped pathways with that of AAA aorta.
Taken together, our results have demonstrated that 1) AVFvenous ECs have signiﬁcant modulations on the gene
expressions of ﬁve secretomes but not the expression of
autophagy SGs; 2) Upregulations of SGs in AVF-venous ECs
result in two pathways in canonical SGs and 13 pathways in
exosome SGs; 3) AVF-venous EC SGs have one canonical
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Trained Immunity Participates in the
Upregulation of Secretomes of
Atherosclerotic Aorta, MERS-CoV
Infection of ECs, Ang-II Induced AAA
Aorta, and CKD aorta but Less in AVF
Venous EC Reprogramming; Trained
Immunity and Immune Metabolic
Reprogramming Are in Different Paces in
Various Diseases; NRF2 and NOX2
Regulate Trained Immunity Partially
Secretomes and cytokines/chemokines play signiﬁcant roles in
promoting immune cell activation, differentiation (polarization),
trans-differentiation (plasticity) in aorta and pathogenesis of
various aortic pathologies (2, 8, 25, 50, 53). As we reported and
reviewed, innate immune cells can develop exacerbated
immunologic response and long-term inﬂammatory phenotype
following brief exposure to endogenous or exogenous insults,
which leads to an altered response towards a second challenge
after the return to a nonactivated state. This phenomenon is known
as trained immunity (TI) (32, 35, 52, 56, 59, 65, 96) (Figure 8A).
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atherosclerosis, three TI promoters were upregulated in AAA,
and only two TI promoters were upregulated in MERS-CoV
infected endothelial cells.
Recent progress reported that hypoxia inducible factor 1
alpha (HIF1a) (102), SET domain containing 7 histone lysine
methyltransferase (SET7), and mechanistic target of rapamycin
kinase (mTOR) promote trained immunity pathways (103)
(Figure 8G). To determine whether HIF1a, SET7, and mTOR
regulate the expression of upregulated secretomic genes in
different disease conditions, we examined the diseaseupregulated SG expression changes in HIF1a−/− GEO database
(GSE29765), SET7 SiRNA database (GSE53038), and mTOR
inhibitor database (GSE138558). As shown in Figure 8F, in
atherosclerosis, HIF1a−/− downregulated 4 canonical SGs and 7
exosomes SGs. In MERS-CoV, HIF1a−/− downregulated 1
canonical SG and 11 exosomes SGs. In AAA and AVF,
HIF1a−/− did not downregulate any SGs. HIF1a−/− in CKD
downregulated one canonical SG, one caspase 4 SG, and one
exosome SG. However, SET7 siRNA in atherosclerosis
downregulated 57 canonical SGs, 10 caspase 1 SGs, 12 caspase
4 SGs, 81 exosomes SGs, one WBP SG, and two autophagy SGs.
SET7 siRNA in MERS-CoV infection downregulated 12 caspase
1 SGs, 8 caspase 4 SGs, 84 exosomes SGs, one WBP SG, and one
autophagy SG. In AAA, SET7 siRNA downregulated 5 canonical
SGs, one caspase 1 SG, one caspase 4 SG, and two exosomes SGs.
In CKD, SET7 siRNA downregulated 20 canonical SGs, 4 caspase
1 SGs, 7 caspase 4 SGs, 39 exosomes SGs, one WBP SG, and one
autophagy SGs. In addition, SET7 siRNA in AVF downregulated
9 canonical SGs, 4 caspase 1 SGs, two caspase 4 SGs, 16 exosomes
SGs, and two WBP SGs. Furthermore, mTOR inhibitor
downregulated 14 canonical SGs and 8 exosomes SGs in
atherosclerosis, but in MERS infection, mTOR downregulated
one canonical SG, two exosomes SGs, and one autophagy SG. In
AAA, mTOR inhibition downregulated only one exosomes SG.
However, mTOR inhibition in CKD downregulated 11 canonical
SGs, 13 exosomes SGs, and one autophagy SG. Finally, mTOR
inhibition in AVF downregulated two canonical SGs and 5
exosomes SGs. These results indicated that SET7 siRNA
downregulated more canonical, caspase 1, caspase 4, and
exosomes SGs than HIF1a−/− and mTOR inhibition.
Taken together, these results have demonstrated that ﬁrst,
trained immunity participates in upregulation of secretomes in
atherosclerotic aorta, MERS-CoV infection of ECs, Ang-II
induced AAA, and CKD aorta but less in AVF venous EC
reprogramming; second, trained immunity gene upregulation peak
time courses are different: atherosclerosis at 72 weeks, MERS-CoV
infection of ECs at 24 h, Ang-II induced AAA at day 7 reach their
peak time in upregulating trained immunity genes, suggesting that
trained immunity establishment and immune metabolic
reprogramming in aorta and aortic ECs are in different pace in
various diseases; third, NOX2 upregulates 3 out of 101 trained
immunity and NRF2 suppresses 10 out of 101 trained immunity
genes, suggesting that ROS partially regulate trained immunity; and
fourth, SET7 deﬁciency play downregulated more canonical, caspase
1, caspase 4, and exosome SGs than HIF1a−/− and mTOR inhibition
in atherosclerosis, CKD, AAA, MERS-CoV infection, and AVF.

We hypothesized that the trained immunity is one of driving
mechanisms underlying the upregulation of SGs. To test this
hypothesis, we examined the expression changes of 101 trained
immunity genes (TIGs) from a comprehensive trained immunity
database (http://www.ieom-tm.com/tidb/browse) in ﬁve vascular
diseases. Of note, the IPA data showed that ﬁve pathways
promoted by 101 TIGs, namely,TREM1 signaling, role of pattern
recognition receptors in recognition of bacteria and viruses, TLR
signaling, role of macrophage, ﬁbroblasts and ECs in rheumatoid
arthritis, and role of hypercytokinemia/hyperchemokinemia in
pathogenesis of inﬂuenza. Furthermore, these TIGs further
classiﬁed into cytokines (21 genes), enzymes (8 genes), kinases
(10 genes), transcription factors (13 genes), transmembrane
receptors (15 genes), phosphatases (3 genes), and others (31
genes) (Figure 8B). There were 1, 11, and 20 TIG upregulations
in atherosclerosis at 6, 32, and 72 weeks, respectively. There were 6,
16, 10, and 6 TIG upregulations in MERS-CoV infected ECs at 12,
24, 36, and 48 h, respectively. There were 25, 3, and 10 TIG
upregulations in Ang-II induced AAA aorta at days 7, 14, and 28,
respectively. There were six TIG upregulation in CKD aorta, and
one TIG upregulation, cardiovascular inﬂammation-promoting
cytokine/adipokine (97) follistatin-like 1 (FSTL1) (98), in AVF
venous ECs, respectively (Figure 8C).
The itaconate pathway and immune-responsive gene 1 (IRG1,
itaconate synthesis enzyme) play signiﬁcant role in promoting
trained tolerance and inhibiting trained immunity and
inﬂammation (99, 100) as shown in Figure 8G. We
hypothesized that IRG1 expression is inhibited when the
expressions of trained immunity genes are upregulated in most
cases. As shown in Figure 8D, IRG1 was upregulated in 78 weeks
atherosclerotic aorta, 48 h MERS-CoV infected ECs, and IRG1
expression was not signiﬁcantly increased in MERS-CoV
infected ECs at 12, 24, and 36 h post infection and day 7 AAA
aorta. Of note, 24 to 36 h at MERS-CoV and day 7 AAA aorta,
trained immunity gene upregulation were at the highest levels
(Figure 8C), which supported our hypothesis in relatively acute
inﬂammations in AAA aorta and MERS-CoV infection except in
chronic atherosclerotic aorta. These data suggested a role of
IRG1 in late atherosclerosis and late MERS-CoV infected
endothelial cells.
We then asked whether ROS regulate the expression of
trained immunity genes. To answer this question, we used two
key ROS regulators, ROS generation enzyme nicotinamide
adenine dinucleotide phosphate oxidase 2 (NOX2) deﬁcient
(knock-out, KO) datasets and ROS-suppressive transcription
factor (TF) Nuclear factor erythroid 2-related factor 2 (NRF2,
NFE2L2) KO datasets as model systems as we reported (21, 35).
As shown in Figure 8C, there were three trained immunity genes
downregulated in NOX2 KO datasets and 10 trained immunity
gene upregulated in NRF2 KO dataset.
IL-1 family cytokines have been reported as drivers and
inhibitors of trained immunity (101). Five IL-1 family
cytokines promote trained immunity (TI) and four IL-1 family
cytokines inhibit TI. We examined the expression changes of
IL-1 family cytokines in different disease conditions. As shown in
Figure 8E, four TI promoters were upregulated in
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FIGURE 8 | Increased trained immunity genes and decreased trained tolerance regulator immune-responsive gene 1 (IRG1) participate in upregulations of SGs in
atherosclerotic, Ang-II induced AAA and CKD aortas, and MERS-CoV infected Ecs. (A) Model of trained immunity. (B) Trained immunity gene list from http://www.
ieom-tm.com/tidb/browse. (After remove 17 duplicated gene by Excel, totally 101 genes involved) IPA analysis of 101 trained immunity genes. (C) Number of
upregulated trained immunity gene in different time course disease and condition. P < 0.05, LogFC>1. (D) The LogFC of IRG1 in different time course and
condition.(P < 0.05). (E) The expression of IL-1 family genes in different condition. IL-1 family genes from PMID: 34844039, P < 0.05, LogFC was showed in table.
(F) Number of downregulated secretomic genes in HIF1a-/- (GSE29765), SET7 SiRNA (GSE53038) and mTOR inhibitor (GSE138558) condition. P < 0.05, LogFC>1.
(G) Working model of trained immunity.
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Among 129 canonical SGs upregulated in CKD aorta, 4 SGs
(3.10%, LogFC <−1) were downregulated in NOX2−/− dataset;
and 13 SGs (10.08%, LogFC >1) were upregulated in NRF2−/−
dataset. Among 23 canonical SGs upregulated in AAA aorta, 0
genes (0%, LogFC <−1) were downregulated in NOX2−/− dataset;
and 1 SG (4.35%, LogFC >1) were upregulated in NRF2−/− dataset.
Among 120 canonical SGs upregulated in MERS-CoV infected
ECs, two SGs (1.67%, LogFC <−1) were downregulated in
NOX2 −/− dataset; and 11 SGs (9.17%, LogFC >1) were
upregulated in NRF2−/− dataset. Among 25 canonical SGs
upregulated in AVF venous ECs, only one gene (4%,
LogFC <−1) was downregulated in NOX2−/− dataset; and two
SGs (8%, LogFC >1) were upregulated in NRF2−/− dataset.
Among caspase 1 SGs upregulated in atherosclerotic aorta (25
genes), CKD aorta (12 genes), AAA aorta (4 genes), MERS-CoV
infected ECs (43 genes) and AVF venous EC reprogramming (8
genes), 0 genes were downregulated (LogFC <−1) in NOX2−/−
dataset; and 8% (atherosclerotic aorta), 8.33% (CKD aorta), 50%
(AAA aorta), 6.98% (MERS-CoV ECs) and 0% genes (AVF
venous ECs) (LogFC >1) were upregulated in NRF2−/− dataset,
respectively. Among caspase 4 SGs upregulated in atherosclerotic
aorta (75 genes), CKD aorta (31 genes), AAA aorta (7 genes),
MERS-CoV infected ECs (61 genes) and AVF venous EC
reprogramming (11 genes), 4% genes in atherosclerotic aorta
were downregulated but no SGs were downregulated in other
datasets (LogFC <−1) in NOX2 −/− dataset; and 22.67%
(atherosclerotic), 19.35% (CKD), 28.57% (AAA), 9.84%
(MERS-CoV ECs) and 18.18% SGs (AVF venous ECs) (LogFC
>1) were upregulated in NRF2−/− dataset, respectively. Among
exosome SG upregulated in atherosclerotic aorta (510 SGs), CKD

ROS-Suppressing NRF2 Plays More
Signiﬁcant Roles in Downregulating SGs
Than That of ROS Generating NOX2 in
Upregulating SGs in Aortic and Vascular
Pathologies; NRF2 Plays More Roles in
Downregulating SGs in Canonical,
Caspase 4 and Exosome Secretomes
Than That in Caspase 1 Secretome; and
NOX2 Plays More Roles in Upregulating
SGs in Canonical and Exosome
Secretomes Than That in Caspase 1 and
Caspase 4 Secretomes
We hypothesized that ROS regulate the expression of secretomes in
aortic pathologies, EC infection by MERS-CoV and AVF venous
EC reprogramming. To examine this hypothesis, we ﬁrst examined
the upregulation of 165 ROS regulators in pathologies. Various
aortic and vascular cell pathologies resulted in upregulation of ROS
regulators: 33 ROS regulators were upregulated in atherosclerosis,
11 ROS regulators were upregulated in CKD-aorta, 15 ROS
regulators were upregulated in MERS-CoV infected ECs, but no
ROS regulators were upregulated in ﬁstula venous EC
reprogramming (Table 4). To determine the causative effects of
ROS regulators in contributing to the upregulation of SGs in aortic
and vascular cell pathologies, we used two key ROS regulators,
NOX2 deﬁcient datasets and NRF2 KO datasets as model systems
as we reported (21, 35). As shown in Table 2, among 259 canonical
SGs upregulated in atherosclerotic aorta, 5 SGs (1.93%,
LogFC <−1) were downregulated in NOX2−/− dataset; and 47
SGs (18.15%, LogFC >1) were upregulated in NRF2−/− dataset.

TABLE 4 | Upregulated secretomic genes in each secretory pathway were screened in Nox2-/- (GSE100671) or Nrf2-/- (GSE7810) dataset.
ID

GSE10000

Disease

Atherosclerosis

ROS regulator (165)

33

LogFC<-1

-1<LogFC<0

LogFC>1

1>LogFC>0

Canonical

Nox2 -/-

Nox2
-/-

Nrf2 -/-

259

20.00%
GSE146638 CKD
GSE47472

Aneurysm

11
6.67%

129

0

23

0.00%
GSE79218

MERS

GSE46126

Fistula

15
9.09%

120

0

25

0.00%
ID

Disease

GSE10000

Atherosclerosis

Caspase4
75

GSE146638 CKD

31

GSE47472

7

Aneurysm

GSE79218

MERS

61

GSE46126

Fistula

11

LogFC<-1

-1<LogFC<0

LogFC>1

>1LogFC>0

Nrf2 -/-

Caspase
1

Nox2 -/-

Nox2
-/-

Nrf2 -/-

25

5

42

47

59

1.93%

16.22%

18.15%

22.78%

4
3.10%

15
11.63%

13
10.08%

22
17.05%

12
4

0

3

1

2

0.00%

13.04%

4.35%

8.70%

2
1.67%

10
8.33%

11
9.17%

17
14.17%

43
8

1

1

2

6

4.00%

4.00%

8.00%

24.00%

LogFC<-1
Nox2 -/-

LogFC<0
Nox2 -/-

LogFC>1
Nrf2 -/-

LogFC>0
Nrf2 -/-

Exosome
510

3

26

17

29

4.00%

34.67%

22.67%

38.67%

0
0.00%

8
25.81%

6
19.35%

6
19.35%

198
66

0

0

2

1

0.00%

0.00%

28.57%

14.29%

0
0.00%

10
16.39%

6
9.84%

3
4.92%

616
82

0

2

2

2

0.00%

18.18%

18.18%

18.18%

Nrf2
-/-

0

7

2

10

0.00%

28.00%

8.00%

40.00%

0
0.00%

4
33.33%

1
8.33%

2
16.67%

0

1

2

0

0.00%

25.00%

50.00%

0.00%

0
0.00%

6
13.95%

3
6.98%

3
6.98%

0

1

0

3

0.00%

12.50%

0.00%

37.50%

LogFC<-1
Nox2 -/-

LogFC<0
Nox2 -/-

LogFC>1
Nrf2 -/-

LogFC>0
Nrf2 -/-

13

114

86

117

2.55%

22.35%

16.86%

22.94%

7
3.54%

32
16.16%

31
15.66%

39
19.70%

0

10

7

3

0.00%

15.15%

10.61%

4.55%

11
1.79%

104
16.88%

37
6.01%

37
6.01%

2

13

2

14

2.44%

15.85%

2.44%

17.07%

P < 0.05. PMID: 31153039. These results have demonstrated that NOX2 may promote trained immunity via increasing reactive oxygen species (ROS) and promote disease-upregulated
secretomic genes; and NRF2 as anti-oxidant transcription factor may suppress ROS and inhibit trained immunity and downregulate disease-upregulated secretomic genes.
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A

B

FIGURE 9 | Under pathological conditions, immune cells in aortas undergo maturation, activation, phenotypic switch and trans-differentiation, which justiﬁes that
aorta serves as an immune organ. (A) Literature based ﬁndings indicate that aorta may play a role as immune organ. (B) A new working model (created in
BioRender.com) has indicated that similar to lymph nodes, a prototypic immune organ, which provide a niche for immune cell maturation, differentiation and
activation, aortas sin pathologies serve as a novel immune organ for immune cells and vascular cells to get activated, matured, differentiated and trans-differentiated.

cells in aortas in response to DAMPs and PAMPs undergo
differentiation and trans-differentiation to promote the
pathogenesis of atherosclerosis, CKD-enhanced aortic
inﬂammation, AAA and AVF reprogramming. However, a key
question remains to be addressed, by what stimuli, in addition to
DAMPs/PAMPs, do those vascular cells and recruited immune
cells differentiate and trans-differentiate. To answer the question,
we performed extensive transcriptomic analyses of six secretomic
gene lists in many microarray datasets deposited in the NIH/
NCBI GeoDatasets database and the EMBL-EBI-ArrayExpress
repository, and made the following ﬁndings: 1) 53.7% out of
21,306 human protein-encoding genes are classiﬁed into six
secretomes; among which four secretomes, canonical, caspase
1, caspase 4 and exosomes, are the large secretomes with >900
proteins; and six secretomes are ranked from the highest
speciﬁcity to the lowest as exosome (83%) > canonical (68%) >
caspase 1 (56%) > caspase 4 (49%) > autophagy (37.5%) > WPB
(8%); 2) Atherosclerosis, CKD, and AAA signiﬁcantly modulate
six secretomes in aortas; and MERS-CoV infection in human
ECs and Angiotensin-II treatment in VSMCs also modulate six
secretomes; 3) Atherosclerotic aortas upregulate T cell and B cell
adaptive immune secretomic genes (SGs); CKD aortas
upregulate SGs for cardiac hypertrophy, hepatic ﬁbrosis and
senescence; and AAA aortas upregulate SGs for neuromuscular
signaling, protein catabolic process and Fcg receptor-mediated

aorta (198 SGs), AAA aorta (66 SGs), MERS-CoV infected ECs
(616 SGs) and AVF venous EC reprogramming (82 SGs), 2.55%
SGs in atherosclerotic aorta, 3.54% SGs in CKD aorta, 0% SGs in
AAA aorta, 1.79% SGs in MERS-CoV ECs, and 2.44% SGs in
AVF venous ECs were downregulated (LogFC <−1) in NOX2−/−
dataset; and 16.86% (atherosclerotic), 15.66% (CKD), 10.61%
(AAA), 6.01% (MERS-CoV ECs) and 2.44% SGs (AVF
venous ECs) (LogFC >1) were upregulated in NRF2 −/−
dataset, respectively.
Taken together, these results have demonstrated that: 1)
NRF2 plays more signiﬁcant roles in downregulating SGs than
that of NOX2 in upregulating SGs in aortic and vascular
pathologies; 2) NRF2 plays more roles in downregulating SGs
in canonical, caspase 4 and exosome secretomes than that in
caspase 1 secretome; and 3) NOX2 plays more roles in
upregulating SGs in canonical and exosome secretomes than
that in caspase 1 and caspase 4 secretomes.

DISCUSSION
Our previous work and those of others have demonstrated that
ECs are innate immune cells in pathological conditions
stimulated by DAMPs/PAMPs. Signiﬁcant progress has been
made to demonstrate that vascular cells and recruited immune
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Others reported that during atherogenesis, VSMCs undergo
phenotypic switching into macrophage-like inﬂammatory cells
(105). We also reported that VSMCs undergo phenotypic switch
stimulated by uremic toxin serum from patients with CKD (17).
Moreover, CD4+Foxp3+ Tregs in aorta experience T helper cell
(Th) lineage plasticity into Th1-Tregs, Th2-Tregs, Th-17-Tregs,
and Tfh-Tregs (106), and antigen presenting cell (APC)-Tregs
(22). We reported that Treg plasticity in mouse aorta is
suppressed by immunosuppressive cytokine IL-35 (25, 53, 55,
107). Studies showed that in both human and experimental
AAAs, prominent inﬂammatory cell inﬁltration, such as CD4+
T cells and macrophages, undergo phenotypic modulation based
on microenvironmental cues. The skew to proinﬂammatory
phenotypes alters disease progression and plays a role in
causing chronic inﬂammation (108). Atherosclerosis immune
responses are controlled by artery tertiary lymphoid organs
(ATLOs) in the adventitial connective tissue adjoining arteries
via VSMC lymphotoxin b Receptors (109, 110). ATLOs recruit
large numbers of B-1 cells whose subtypes are skewed toward IL10+ B-1b cells versus IL-10- B-1a cells (110). Germinal centerderived IgG antibodies promote the size and stability of
atherosclerosis plaques, through promoting arterial SMC
proliferation and maintaining the molecular identity of the
aorta (111). Single cell RNA sequencing identiﬁed 17 types of
aortic cells including 11 principal leukocyte clusters (112), which
include ﬁve types of macrophages (mac) such as interferoninducible (IFNIC)-mac, inﬂammatory mac, monocyte (mono)/
mac/dendritic cell (DC)/CD209a (monocyte-derived DC) (113),
resident mac, triggering receptor expressed on myeloid cells-2
(Trem2) foamy mac. These ﬁndings suggest immune cell
activation, polarization, differentiation/trans-differentiation and
diversity in aorta (114). Taken together, all these ﬁndings suggest
that under pathological conditions, immune cells in aortas
undergo maturation, activation, phenotypic switch and transdifferentiation, which justiﬁes that an aorta serves as an immune
organ (Figure 9A).
The original microarray experiments deposited in the
NCBI database used mouse aortas in different pathologies,
which prevented us from comparing the secretomic gene
expressions in the same -omics analysis settings. In addition,
since the transcriptomic experiments were performed in many
different laboratories, variations between the results cannot be
ruled out due to different experimental conditions. Of note, a
similar method was used in Figure 4b of the Nature
Immunology paper from Drs. Mathis and Benoist teams
(115). Although our database mining approach was not ideal,
however, as the ﬁrst step to ﬁll in the important knowledge gap
this approach was justiﬁed, which becomes a common practice
that we (21) and others (116) often used. Another limitation of
the current study is that due to the low throughput nature of
current veriﬁcation techniques in the laboratories, we could not
verify the results we identiﬁed with the analyses of high
throughput data. Of note, many of those high throughput
datasets have been published in papers of other investigators
with experimental veriﬁcation on some data. We acknowledge
that carefully designed in vitro and in vivo experimental models

phagocytosis; 4) Canonical secretome in atherosclerotic aortas
upregulate pattern recognition receptors, leukocyte extravasation
at 6 weeks, T cell exhaustion, ﬁbrosis and neuroinﬂammation at
32 and 78 weeks; caspase 1, and caspase 4, GSDMD secretomes
have no functions at 6 weeks, but have functions of cancer
metastasis, NFAT and B cell signaling at 32 and 78 weeks,
respectively; and exosome secretome has eNOS, and calcium
signaling at 6 weeks but GF-CSF, NFAT, and T cell signaling at
32 and 78 weeks; 5) In Ang-II induced AAA, canonical, caspase
4-GSDMD, and exosome secretomes have two peaks (threephases) of high (day 7)-low (day 14)-high (day 28) expression
patterns; and caspase 1-GSDMD, Weibel–Palade body, and
autophagy secretomes are only functional at the day 7; 6)
Elastase-induced AAA aortas have more inﬂammatory and
immune pathways than that of Ang-II induced AAA aortas; 7)
Most disease-upregulated cytokines and chemokines in aorta are
secreted via canonical and exosome secretory pathways but not
caspase 1 and caspase 4-GSDMD secretory pathways; 8)
Canonical and caspase 1 secretomes play roles at early MERSCoV infection whereas caspase 4 and exosome secretomes play
roles in the chronic phase infection; and the early upregulated
canonical and caspase 1 secretomes may function as drivers for
trained immunity; 9) Venous ECs from AVF upregulates genes
in ﬁve secretomes, resulting in two pathways in canonical
secretome and 13 pathways in exosome secretome; 10) Trained
immunity participates in the upregulation of secretomes of
atherosclerotic aorta, MERS-CoV infection of ECs, Ang-II
induced AAA aorta, and CKD aorta but less in AVF venous
EC reprogramming; trained immunity and immune metabolic
reprogramming are in different pace in various diseases; NRF2
and NOX2 partially regulate trained immunity; and 11) ROSsuppressing transcription factor NRF2 plays more signiﬁcant
roles in downregulating secretomic genes than that of ROS
generating enzyme NOX2 in upregulating secretomic genes in
aortic and vascular pathologies; NRF2 plays more roles in
downregulating genes in canonical, caspase 4 and exosome
secretomes than that in caspase 1 secretome; and NOX2 plays
more roles in upregulating genes in canonical and exosome
secretomes than that in caspase 1 and caspase 4 secretomes.
The major rationale for classifying lymph nodes and spleen as
peripheral immune organs is that these organs provide a niche
for immune cell maturation, differentiation, and activation (104).
If we hold the same criteria and examine recent progresses in the
aorta ﬁeld, we will have no difﬁculties to conclude that aorta is an
immune organ in pathologies. Previously, we reported that ECs
including human aortic ECs are innate immune cells (3, 32, 35).
Our RNA-Seq paper showed that human aortic ECs activated by
LysoPC are trans-differentiated into innate immune cells by
upregulating EC adhesion molecules, cytokines/chemokines,
additional DAMP receptors, MHC molecules (51); costimulation receptors and immune checkpoints (57) are
upregulated in other ECs stimulated by proinﬂammatory
cytokines such as TNF-a and IFN-g (57); and a comprehensive
list of innate immune regulators (innatome) are signiﬁcantly
upregulated in 28 various types of ECs stimulated by conditional
DAMPs and PAMPs including SARS-CoV-2 (COVID-19) (35).
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will be needed to continuously verify the ﬁndings
presented here.
To summarize our ﬁndings here, we propose a new working
model (Figure 9B). First, peripheral lymphoid organ, lymph
nodes, where naïve lymphocytes and other immune cells
become activated, or differentiated/polarized into effector
subsets. By comparison, in aorta during atherosclerotic and
other pathologies, endothelial cells get activated, vascular
smooth muscle cells (VSMCs) become phenotypical switched
into macrophages/monocytes-like VSMCs, monocytes become
Ly6C+/high proinﬂammatory ones, macrophages are polarized
into M1 and other effector subsets, CD4+ Tregs become plastic
into Th1-like, Th17-like and other status in addition to maintain
their immunosuppressive functions; second, signiﬁcantly
upregulated six types of secretomes, namely, canonical, caspase
1-GSDMD, caspase 4-GSDMD, exosome, WPB, and authophagy,
promote the establishment of niches for immune activation,
differentiation (polarization), and trans-differentiation (plastic);
and third, trained immunity promoters, IL-1 family cytokine
trained immunity promoters, HIF1a, SET7, mTOR, and ROS
generator NOX2 (60) as underlying mechanisms contribute to
the upregulation of aortic and vascular cell secretomic genes
whereas trained tolerance promoter IRG1, IL-1 family cytokine
TI inhibitors and anti-oxidant transcription factor NRF2 are
underlying mechanisms for inhibition of secretomic gene
upregulation in pathologies. Recently several single cell
RNA-Seq analyses (117) deposited in the Single Cell Porter
database (https://singlecell.broadinstitute.org/single_cell?type=
study&page=1&terms=aorta) in identifying numerous subtypes
of monocytes, endothelial cells, ﬁbroblasts support this new
working model. Therefore, aortas can be classiﬁed into an
immune organ, which express immune regulatomic genes such
as receptors for virus infections, DAMPs/PAMPs (PPRs),
cytokines (54), chemokines (50), cell death (8), growth factors
(50), immune checkpoints (57), and regulators for trained
immunity (59)-related metabolic and epigenetic reprogramming

(118), and play signiﬁcant roles in vascular homeostasis,
inﬂammatory cell recruitment, myelopoiesis, innate immunity,
cell death, thromboembolism, cytokine storms and cardiovascular
comorbidities of COVID-19 and other viral infections. We believe
that extensive future work are needed to re-examine the highthroughput results reported here with relatively low throughput
methods currently in most laboratories. Nevertheless, our ﬁndings
provide novel insights on the roles of upregulated secretomic
genes in the pathogenesis of various aortic and vascular
inﬂammatory diseases and also new targets for the future
therapeutic interventions for inﬂammations, CVDs, autoimmune
diseases, transplantation and cancers.
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